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ABSTRACT 
Tuberculosis (TB) is still one of the most highly elusive lethal transmittable diseases to 
eradicate and persist to be a major threat to public health due to emergence of drug resistance.  
Drug-resistant is steadily increasing worldwide, therefore, there is an urgent need for 
development of improved efficacious antibiotics and novel drug targets to successfully contain 
the disease.  Peptidoglycan layer (PG) is the major attribute in bacterial cell envelope and is 
essential for protection and growth in all bacterial species including Mycobacterium 
tuberculosis(Mtb). 
The biosynthesis pathway for PG is extremely intricate and involves numerous interconnected 
metabolites such as N-acetylmuramic(NAM) acid and N-acetylglucosamine(NAG), that are 
required during transpeptidation.  These two sugar molecules are linked together by a β (1-4) 
glycosidic bond and the NAM attaches 3-5 amino acid peptide stems.  Consequently, the 
peptidoglycan strands are cross linked by transpeptidases, namely D, D- and L, D-
transpeptidases, forming crucial 4→3 and 3→3 cross-linkages respectively.  Both D, D- and 
L, D-transpeptidases need to be inhibited concomitantly to eradicate the bacterium.  L, D-
transpeptidase 2 (LdtMt2) is one of the paralogs that is essential for Mtb growth, cell morphology 
and virulence during the chronic stage of the disease.  This paralog has major influence in drug 
resistance and persistence of tuberculosis. 
The traditional β-lactam family of antibiotics have been reported to be effective against Mtb 
following the inactivation of β-lactamases (BlaC) known to rapidly hydrolyze the core β-lactam 
ring.  The classic penicillins inhibit D, D-transpeptidases, while L, D transpeptidases are 
blocked by carbapenems.  Despite several studies in this field, to the best of our knowledge, 
limited attention has been paid to the inhibition mechanism of LdtMt2 using carbapenem 
derivatives.  In this regard, we need to explore reliable alternative strategies that are most cost-
effective in terms of investigating the interactions of FDA approved carbapenems against Mtb 
L, D-Transpeptidases and study the role of explicit water molecule confined in the active site.  
As a result, computational chemistry has provided the possibility to sightsee and investigate 
this problem with relatively cost effective computational techniques. 
In this thesis, we applied a hybrid quantum mechanics and molecular mechanics techniques 
(QM:MM), Our own N-layered Integrated molecular Orbital and Molecular Mechanics 
(ONIOM) approach, to investigate the binding interaction energies of carbapenems (biapenem, 
imipenem, meropenem and tebipenem) against L, D-transpeptidase 2.  Furthermore, the role of 
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explicit water molecule confined in the active site was also explored using the same hybrid 
method to ascertain the nature of binding interaction energies of carbapenems against LdtMt2.  
In all the investigated carbapenem─LdtMt2 complexes, the carbapenems and the catalytic active 
site residues of LdtMt2 (Cys205, His187, Ser188, His203 and Asn207) were treated at QM 
(B3LYP/6-31+G(d)) level of theory whereas the remaining part of the complexes were treated 
at MM level (AMBER force field).  The explicit water molecules near the carbapenems were 
considered and treated at QM as well. 
The obtained findings of Gibbs free energy (G), enthalpy (H) and entropy (S) for all 
studied complexes showed that the carbapenems exhibit reasonable binding interactions 
towards LdtMt2.  This can be attributed by the structural dissimilarities of the carbapenems side 
chain which significantly induce conformational changes in the LdtMt2.  In comparison, the 
binding free energy calculations of the model system with explicit water molecule yielded 
significant binding interaction energies.  The QTAIM and NBO results confirmed the nature 
of binding free energies that the topological properties of atoms in molecules and the 
delocalization of electrons are from a bonding to antibonding orbitals in hydrogen bond 
interactions and this has enhanced the stability of carbapenem―LdtMt2 complexes.  We believe 
that molecular insight of the carbapenems binding to LdtMt2 and the role of explicit solvent will 
enable us to understand the inhibition mechanisms. 
Keywords: Tuberculosis (TB); Mycobacterium tuberculosis (Mtb); L, D-transpeptidase2 
Carbapenems; Our own N-layered Integrated Molecular Orbital and Molecular Mechanics 
(ONIOM); Quantum theory of atoms in molecules (QTAIM); Natural bond orbital (NBO). 
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CHAPTER ONE 
INTRODUCTION 
1.1 Preface 
Tuberculosis (TB) is an infectious disease commonly caused by acid-fast Gram-positive strains 
of Mycobacterium tuberculosis bacilli.  TB is regarded as one of the foremost global health 
issues 1, 2 and the most important infectious disease after HIV/AIDS.  Recently, the World 
Health Organization announced a new statistical report with an estimated 10.4 million TB 
cases, which indicated a rapid increase of both morbidity and mortality rate 2. Approximately 
95% of TB deaths worldwide are most prevalent in developing countries 2.  The disease is an 
easily transmittable airborne infection that spreads when people who have active TB sneeze, 
cough, speak or spit 3.  TB control is much obfuscated by the co-operation of HIV which 
triggers the reactivation of latent mycobacterium tuberculosis (Mtb) persisters and has led to 
the emergence of drug-resistant strains of M. tuberculosis 4-6.   
The sub-Saharan Africa region suffers the highest incidents of TB while the highest TB-burden 
occurs in populous countries such as India, Asia, Bangladesh, China, Indonesia, Pakistan, 
Nigeria and South Africa 7.  In 2014, the WHO estimated the incidence of TB in South Africa 
to be 860 (776–980) per 100,000 population, which contributed to it becoming amongst the 
highest burden countries in the world 8. 
The remarkable resurgence of TB disseminated via the emergence of drug-resistance has 
resulted in high morbidity and mortality rates 9.  Successful treatment for TB, discovered 40-
50 years ago 10, requires the use of multiple antibiotics referred to as front-line drugs (isoniazid, 
rifampicin, pyrazinamide, and ethambutol) and patients are subjected to a treatment period of 
6-9 months.  These frontline drug-regimens for drug-susceptible TB are noted to have some 
side effects if they are improperly used 11, 12.  There are two types of drug-resistance 
tuberculosis, multi-drug resistance (MDR-TB)13 and extensively drug resistance (XDR-TB) 13 
tuberculosis, respectively.  MDR-TB is defined as the resistance of mycobacterium 
tuberculosis strain against isoniazid and rifampicin.  XDR-TB is referred to mycobacterium 
tuberculosis strains that are multi-drug resistance to almost all anti-tubercular drugs, including 
second-line drugs.  Several years ago, an epidemic of drug-resistant TB, multidrug-resistant 
TB, and extensively drug-resistant TB, which are highly fatal, tremendously expensive and 
intricate to treat, emerged globally 14.  The major challenge in South Africa is the inadequacy 
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of TB control tools for detecting isoniazid resistance, the first resistance mutation to be 
acquired, since the current molecular diagnosis tools only assess rifampicin resistance 15.  
Instances of drug resistance strains in South Africa were traced back to the late 1950s (XDR) 
and 1980s (MDR) 15.  The study conducted by Gandhi et al. 16 in the KwaZulu-Natal province 
indicated that the F15/ LAM4/KZN strain type prevailed among MDR TB and XDR TB cases 
and has led to nosocomial transmission and high mortality rates 17, 18.   
South Africa is ranked sixth in the world in new TB incidents among the 22 countries that 
express an extreme TB-burden estimated to contribute about 80% of TB cases across the globe 
7.  As a result, MDR-TB and XDR-TB persist in being a serious public health concern 19.  
Therefore, there is an urgent need for the development of new potent drug therapies aimed at 
counteracting resistant Mtb strains and which can also be co-administered with HIV 
antiretroviral drugs. 
1.1.1 Tuberculosis as a global health issue and co-epidemic with HIV 
During the early 1980s, the HIV epidemic led to a major rise in TB cases and TB mortality in 
many countries, especially in southern and eastern parts of Africa 20.  Immunocompromised 
HIV-positive patients have a high probability to develop active TB infection and significantly 
enhance the risk of mycobacterium tuberculosis reactivation which in turn constitutes many 
deaths worldwide 21, 22.  Also, HIV co-infection convolution aggravates TB thus increasing the  
incidents of drug resistant cases by disseminating the infection, while HIV replication is also 
enhanced in other organs such as the lungs and pleura 23, 24.  Approximately 80% of people 
infected with HIV in the KwaZulu-Natal, are co-infected with active tuberculosis 25.  Of the 
people co-infected with HIV and TB in South Africa, an estimated 20% have a MDR strain.  
In fact, the disease burden in KwaZulu-Natal has been accentuated by the outbreak of XDR-
TB among HIV-positive individuals reported in 2005 25. 
In 2015, an estimate of 0.4 million HIV-co-infected TB patients passed on and most deaths 
were due to TB infection.  The actual number of estimated TB deaths in 2015 according to 
WHO was 1.4 million 26.  In an estimated 1.2 million new TB cases amongst HIV-infected 
people, the majority of about 71% come from people living in Africa.  Although antiretroviral 
therapy is available for HIV infected individuals, their potency in controlling HIV-associated 
morbidity and fatality is thus diminished if tuberculosis programmes are not enhanced 27, 28.  
Regimens that can provide safe co-operation with antiretroviral therapy are critically needed. 
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1.1.2 Mycobacterium tuberculosis and its life cycle  
Mycobacterium tuberculosis is a rod-shaped, non-motile, aerobic Gram-positive bacillus that 
was first discovered by the German scientist, Dr Robert Koch, in1882 29.  M tuberculosis is an 
obligate intracellular bacterium that requires a high oxygen content environment for its 
survival, therefore the lungs are primarily targeted.  Mtb can infect a variety of animal species 
and humans.  Mtb is a non-spore forming bacteria which can remain alive for years in a 
latent/dormant state 30 and its replication process differs to other bacteria as it divides every 
15-20 hours, which is extremely slow.  It is a persistent pathogen and it shares common 
characteristic features with other infectious agents responsible for sustained infections 31. 
Mtb infection instigates upon pulmonary exposure, resulting from inhalation of active bacilli 
from the atmosphere 32.  The chances of being infected by active bacilli are influenced and 
escalated by various “infrastructural” factors, that often involves overcrowded conditions with 
respect to work, transport, schools and the living environment 33.  Prior to bacilli 
internalization, innate immune response or pro-inflammatory response from the host is 
stimulated to release phagocytic cells to contain mycobacterium tuberculosis 30, 34 which are 
then transported towards the alveolar epithelium layer in the lungs.  The infected macrophages 
call upon other mononuclear cells and T lymphocytes from the surrounding blood vessels to 
form organized dynamical structures known as granulomata 34.  
As the primary lesion matures into granuloma, the infected macrophages are surrounded by a 
number of foamy macrophages and a fibrous cuff forms while the central region of the 
granuloma accumulates caseous debris (Figure 1) 30, 35, 36.  The active form of tubercle in the 
caseous region dissipates through blood plasma to various parts of the body, ultimately 
resulting in active bacilli being expelled into the environment via the lungs and sputum.  
Mycobacterium tuberculosis can remain within the host organism for quite lengthy periods in 
dormant state and can still resuscitate 30.  Immunocompetent HIV infected individuals are most 
prone for Mtb reactivation. 
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Figure 1.  Schematic diagram representation of mycobacterium tuberculosis life cycle during 
infection 30. Reprinted with permission from reference 50. Copyright 2012. Federation of 
European Microbiological Societies (FEMS). 
1.1.3 Mycobacterium tuberculosis composition  
1.1.3.1 Cell wall structure 
The cell envelope of M. tuberculosis is a highly intricate hydrophobic arrangement of distinct 
glycolipids and mycolic acids.  Mycolic acids are elongated chains of branched fatty acids 
either covalently bound to the cell wall or to the toxic form of glycolipid, trehalose dimycolate 
(TDM)37.  The cell wall is made up of two layers, the inner- and the outer-layer, bound by a 
plasma membrane 38.  The outer membrane bound layer is composed of lipids and proteins 
freely linked to the cell wall with fatty acid chains matching the inner membrane-bound layer 
fatty acids.  The inner membrane bound layer comprises of mycolic acids (MA), 
arabinogalactan (AG), and peptidoglycan (PG) covalently tethered together to form a MA-AG-
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PG complex that outspreads from the plasma membrane beginning with PG and ending with 
MAs 38.  The PG complex structure enhances the protection in mycobacterium tuberculosis 
against various drugs that are unable to penetrate through the cell wall and reach the cytoplasm 
to successfully destroy the cells.   
The complex structure of the cell wall also consists of muropeptide sugar molecules, N-
acetylglucosamine (NAG) and N-acetylmuramic acid (NAM) 39.  These sugar molecules are 
linked to each other through a β (1-4)-glycosidic bond in affiliation with three to five amino 
acid-long peptide stems 39-41.  The peptidoglycan layer is crucial to maintain rigidity and turgor 
pressure thus, serves as a structural permeability barrier in the cell envelope 42.  A mesh-wax-
like coat of mycolic acid and glycolipids are joined to arabinogalactan that is successively 
linked to N-acetylmuramic acid subunits in the peptidoglycan layer 43.  Mtb share a common 
peptide-stem sequence with Escherichia coli and M. subtilis but with minor distinctions 40.   
The amidation on the D-glutamate (D-Glu), diaminopimelate (Dap) moieties and a high 
proportion (80%) of Dap-Dap (3→3) transpeptide linkages are catalysed by the enzyme L, D-
transpeptidase and 20% of cross-linkages, the classical 4→3 are catalysed by D, D-
transpeptidase also known as penicillin binding proteins 39, 44, 45.  Mtb L, D-transpeptidases are 
susceptible to β-lactam antibiotics as a result of effective inactivation of chromosomally 
encoded β-lactamase known to hydrolyse the β-lactam ring of carbapenems 46. 
1.1.3.2 Peptidoglycan layer 
Peptidoglycan (PGN) is a key component of the bacterial cell envelope in both Gram-negative 
and Gram-positive bacteria.  The peptidoglycan layer forms part of the structural basis for most 
bacteria as it is made of macromolecules that encompasses the cytoplasmic membrane to 
protect the bacterium from exploding due to the osmotic pressure of the cytoplasm 47. 
Peptidoglycan provides protection as it serves as a framework for attaching various surface 
polymers to maintain the integrity and overall shape of the persisters.  The action of enzymes, 
glycosyltransferases in polymerization and transpeptidases in cross-linkages formation of the 
peptide stems, help congregate the peptidoglycan from sugar pentapeptide subunits 48, 49.  The 
peptidoglycan layer is formed from two alternating amino sugars N-acetylmuramic acid and N-
acetylglucosamine, held together by a β-1, 4 glycosidic bond, coupled by a short oligopeptide 
stem attached to mycolic acids and glycolipids, that forms a wax-like coat in the outer layer, 
covalently linked to arabinogalactan 43.   
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The biosynthetic route of peptidoglycan is a complex process that initiates in the cytoplasm 
with the synthesis of a muramyl pentapeptide precursor comprising a terminal D-Ala-D-Ala.  
Bacterial N-acetylglucosamine synthesis from fructose-6-phosphate involves four enzymes to 
successfully complete the synthesis of the peptidoglycan layer that includes 39: glucosamine-
6-phosphate synthase (GlmS), phosphoglucosamine mutase (GlmM), glucosamine-1-
phosphate acetyltransferase and N-acetylglucosamine-1-phosphate uridyltransferase (GlmU) 
39.  GlmS is an aminotransferase enzyme that is essential for the conversion of fructose-6-P to 
glucosamine-6-P through the activity of fructose-6-phosphate aminotransferase (GlmS) using 
L-glutamine 39, 50.  GlmM is involved in the biosynthesis process of UDP-GlcNAc by 
isomerizing glucosamine-6-P to glucosamine-1-P, respectively 39, 51.  The two final steps of 
cell wall biosynthesis are catalysed by N-acetylglucosamine-1-phosphate uridyltransferase 
(GlmU).  GlmU is a bifunctional enzyme that catalyse the acetyltransfer from acetyl-coA to 
glucosamine-1-phosphate (GlcN-1-P) to yield  N-acetylglucosamine-1-phosphate (GlcNAc-1-
P) which is then converted to UDP-GlcNAc by uridyltransfer from uridine 5-triphosphate 
(UTP) in the presence Mg2+ 52. 
The UDP-GlcNAc, the precursor for NAG, is transformed to UDP-MurNAc upon addition of 
the lactyl group to glucosamine.  The UDP-MurNAc is then converted to UDP-MurNAc 
pentapeptide by addition of five amino acids including the dipeptide D-alanyl-D-alanine.  The 
metabolic pathway of L-alanine is basically formed through reductive amination process of 
pyruvate (Figure 2).  As a consequent, the bacterial cell wall requires the D-alanine precursor 
for peptidoglycan biosynthesis and for survival.  Therefore, the L-alanine precursor is 
predominantly available as a source of nitrogen in most bacteria 53.  
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Pyruvate + NADH + 2H L-alanine + NAD+
L-alanine dehydrogenase
(ald, Rv2780)
Aerobic
Anaerobic
+ H2O
D-alanine
Alanine racemerase
(alr, Rv3423c)
D-ala-D-ala ligase
(ddlA, Rv2981c)
D-alanine-D-alanine
Peptidoglycan  
Figure 2.  Illustrative representation of interconversion of L-alanine to D-alanine during 
peptidoglycan biosynthesis 54. 
The alanine racemase is dependent on pyridoxal phosphate for catalysing the interconversion 
of L-alanine amino acid into D-alanine, the essential precursor for peptidoglycan, which then 
joined to D-alanyl-D-alanine moiety through the action of D-Ala-D-Ala ligase (Figure 2) 55, 
56.  PG is covalently linked to arabinogalactan that is also connected to mycolic acid lipid layer 
that consists of three classes of lipids (alpha-, keto- and methoxymycolates) (Figure 3) 57.  The 
oxygenated mycolic lipid layer plays a significant role in inducing the growth of 
mycobacterium tuberculosis’s intra-macrophages 58.  Mycolic acids vary in their configuration 
as alpha-mycolic acids have two cis-configuration cyclopropane rings while keto- and 
methoxymycolates have either cis- or trans- configuration of the cyclopropane ring.  
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Figure 3. Schematic diagram of mycobacterium tuberculosis cell wall composition 59.  
Reprinted with permission from reference 69. Copyright 2011. Yale Journal of Biology and 
Medicine (YJBM). 
1.1.4 L, D-Transpeptidase function and structure 
L, D-transpeptidases (Ldt) are regarded as a novel family of peptidases comprising of a cysteine 
residue in the active-site and is different from D, D transpeptidases by having serine as a 
catalytic residue.  Ldt function by catalysing the formation of crucial 3→3 cross-linkages and 
also serves numerous other cellular functions 60.  The primary step of Ldt involves the 
nucleophilic attack of the meso-diaminopimelic acid (meso-Dap3) carbonyl of the tetrapeptide 
stem, which then lead to the formation of the thioester bond between carbonyl and catalytic 
cysteine of L, D-transpeptidase.  The secondary step involves the nucleophilic attack of the 
subsequent acyl enzyme by the amine group of the meso-Dap3 side chain from the second stem-
peptide substrate thus resulting in the formation of 3→ 3 cross-linkages.  Consequently, the D, 
D-transpeptidases is also playing a critical role in the biosynthesis process of the peptidoglycan 
layer by catalysing the formation of 4→3 cross-linkages (D-Ala4─meso-Dap3) 61.  In most 
bacterial species, L, D-transpeptidases have an insignificant role of forming 3→3 cross-
linkages during the biosynthesis process of peptidoglycan as observed in  Escherichia coli  
where the 3→3 cross-linkages were formed during the exponential and stationary phases of 
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growth 62.  Mycobacterium tuberculosis exhibit elevated content of about 80% 3→3 cross-
linkages compared to other bacterial species 63.  Previously, L, D-transpeptidase 2, LdtMt2 
(MT2594, the product of gene Rv2518c), was characterized in Mtb, which thus proved that the 
loss of virulence and deteriorated growth in Mtb strain was reliant to the lack of LdtMt2 during 
the chronic phase of the disease 64.  Apart from LdtMt2, Mtb has four other paralogs of which 
one, LdtMt1, displays LdtMt2 properties (LdtMt1-LdtMt5) 
45, 63.  Previous studies show that L, D-
transpeptidase (Ldtfm) in mutated Enterococcus faecium plays a significant role in favour of 
the pathogen’s survival as it triggers the adaptive response to β-lactam antibiotics which are 
hydrolysed by lactamase enzyme thus promoting elevated level of drug resistance. 
1.1.4.1 Structure of L, D-transpeptidase 2 
The L, D-transpeptidase enzyme (PDB code: 3TUR) 65 comprises of two chains, A and B with 
527 amino acids 65.  Each chain contains two domains; the N-terminal domain extending with 
150-250 residues, held in an antiparallel fold and a C-terminal catalytic domain extending by 
254-407 residues 65.  These two domains are joined together by a short stretch of residues (251-
253) making a complete functional protein 60.  The active site lid includes His300-Asp323 
residues in a spiral loop of two normal β-sheets.  The active site of L, D-transpeptidase 
comprises of a catalytic triad of Cys354, His336 and Ser337 residues with His336 and Ser337 
being buried in the cavity while Cys354 is exposed to bulk solvent and is reachable through 
two paths (A, B) 66. 
 
Figure 4.  3-D structure of LdtMt2 showing active site lid in an open conformation 
65, 66.  
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1.1.5 Application of carbapenems antibiotics 
Carbapenems are a subfamily of β-lactam antibiotics that were discovered by Merck & Co 
from the soil bacteria Streptomyces cattleya 67.  These compounds exhibit a broad spectrum of 
activity with bactericidal effects against Gram-negative and Gram-positive bacteria including 
both aerobic and non-aerobic species 68.  The β-lactam antibiotics resemble the peptide 
precursor of the peptidoglycan layer, NAM/NAG chain, by having a D-Alanyl-D-Alanine 
configuration at the terminal amino acid residues.  These features allow antibiotics to easily 
bind to the penicillin binding protein (PBP) site and irreversibly bind to the active site serine 
residue, thus preventing the formation of cross-linkages thereby causing disruption of the cell 
wall 69.  The carbapenems vary mainly in their side chain configuration at C2 and C6 which 
also reflects their variant stability, resistance, stimulation, and inhibition of the β-lactamase 
enzyme 70.  Carbapenems structurally differ from other β-lactams in that position 1 is 
substituted with a sulphur atom and a double bond is present between C2-C3 of the 5-
membered ring as depicted in Figure 5. 
N
O
Ra
Rb
Rc
COOH
1
2
34
5
6
7
H
 
Figure 5.  Structural core of β-lactam antibiotic 
The combination of a β-lactamase inhibitor (clavulanate) and amoxicillin shows an efficient 
bactericidal effect against TB infected patients and even those that were reported to have 
developed resistance by inhibition of the mycobacterium β-lactamase (BlaC) enzyme 46, 71, 72.  
Previous studies reveal that the LdtMt2 enzyme is very susceptible to amoxicillin-clavulanic 
acid 45. 
Dehydropeptidase (DHP-1) is an enzyme located in the renal tubule of the kidney and has an 
ability to degrade imipenem.  Imipenem remains unchanged in solution and possesses a wide 
spectrum of activity against aerobic and anaerobic bacteria 73, 74.  Imipenem was recommended 
clinically to be co-administered with cilastatin following rapid degradation by the DHP-1 67, 70.  
However, meropenem was later approved for clinical use as it was stable against DHP-1 
degradation and is also resistant to Mtb BlaC β-lactamase and can therefore be administered 
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alone 70.  Disruption of the permeability barrier of the cell wall components will increase the 
ability of antibiotics penetration towards the inside of the cell.  Therefore, full inhibition of L, 
D transpeptidase is essentially a significant way to curb the proliferation of mycobacterium 
tuberculosis and thus more insight on mechanism of carbapenems can provide useful 
information for rational drug design.  The loss of LdtMt2 in M. tuberculosis leads to a 
transformed cell size, growth, and virulence which thus exposes the bacterium to increased 
susceptibility to amoxicillin 75, 76.  However, it was pointed out before, that inhibition of both 
LdtMt1 (first generation β-lactams) and LdtMt2 (carbapenems) would offer a better chance of 
avoiding the development of drug resistance 77.   
Previous experimental literature stated that imipenem irreversibly inhibited LdtMt1 which is 
known to contribute in the formation of 3→3 transpeptide cross-linkages 78.  Lavollay et al. 63 
conducted a study of this enzyme believed to have generated major cross-linkages during the 
stationary phase of Mycobacterium tuberculosis. In their findings, LdtMt1 was also associated 
with the structural adaptation of the pathogen during the non-replicative state 63.   
Studies exploring carbapenem mechanism of inhibition against LdtMt2 have authenticated their 
potency against extensively drug-resistant TB strains and are therefore well suited as possible 
drug candidates for TB treatment 65, 66, 79.  In-vitro studies demonstrated that penems 
(faropenem) and the carbapenems (doripenem, biapenem and tebipenem) have bactericidal 
activity against Mycobacterium tuberculosis in the absence of β-lactamase inhibitors 80. 
Lately, several computational methods have been used to study carbapenems against LdtMt2 
which provided very useful molecular views of possible mechanisms of inhibitors and the 
receptor 65, 75, 77, 81-83. 
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1.1.6 Computational work and importance of the study  
The peptidoglycan biosynthesis pathway is a key functional process necessary for 
mycobacterium tuberculosis morphology and growth and has been intensively explored by 
Lamichhane et al. 75. The functions performed by various Mycobacterium tuberculosis 
enzymes yield fundamental metabolites required in the peptidoglycan biosynthesis.  This 
includes vital targets for rational drug design (GlmS, GlmM, GlmU, MurA, MurB, MurC, 
MurD, MurE and MurF) which the bacterium utilizes to synthesize the rigid architectural 
peptidoglycan layer.  In that study, the essential metabolites of an organism were identified 
using genetic and biochemical techniques and then afterwards followed by application of 
computational approaches, Discovery Studio 2.5.5, to retrieve the mimics of the essential 
metabolites by pharmacophore identification 75. 
Recently, studies exploring the catalytic mechanism of L, D transpeptidase 2 from 
mycobacterium tuberculosis emerged 81 giving more insight into the binding interactions 
between the substrate and LdtMt2.  In that study, the experimentally proposed mechanism for 
LdtMt2 was extensively investigated by quantum mechanics/molecular mechanic (QM/MM) 
molecular dynamic (MD) simulations.  The free energy results obtained by PMF analysis 
agreed with the proposed experimental mechanism and have shown that the acylation step is 
the rate-limiting step in the catalytic mechanism.  A comprehensive analysis of the substrate-
protein interactions revealed the significance of involved residues, such as Met303, Tyr318, 
Trp340, His352, and Asn356, in binding of the substrate and stabilization of the transition state 
81.  Silva et al. 77 also investigated the mechanism of the inhibition reaction of mycobacterium 
tuberculosis L, D-transpeptidase 2 by carbapenems using hybrid QM/MM MD simulations and 
a QM/MM umbrella sampling technique to obtain the free energy profile for LdtMt2 catalytic 
mechanism.  According to the proposed mechanism, the acylation step was confirmed to be 
preceded by a thiol–imidazole pair formation (Cys354 and His336 catalytic residues) in its 
zwitterionic form.  The significance of this mechanism reveals that during acyl-enzyme 
formation the His336 plays a crucial role in proton abstraction from Cys354 thiol group which 
fulfil the acylation step.  In this regard, the theoretical findings with the new proposed 
mechanism agreed in principle with the experimental data. 
Considering the significance of Cys354, His336 and water molecule during acylation of β-
lactams, the proceeding theoretical MD simulation study conducted by Silva et al. 84 explored 
the binding affinities of imipenem and meropenem against LdtMt2.  The binding free energies 
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for inhibitor/ex-LdtMt2 complexes were calculated from a 25 ns MD simulation using 
MM/GBSA and SIE approaches and the obtained findings from the study revealed that 
imipenem complex adopted a closed conformation while for meropenem complex remained in 
an open conformation after the whole MD simulation.  This further required validation by 
longer MD simulation runs to bring more insight on conformational opening and closing of the 
complexes 84.  Consequently, the β-hairpin flap dynamics seem to have a major contribution in 
accommodating the inhibitor within the pocket binding site.  Recently the MD simulation study 
exploring differential flap dynamics in LdtMt2 revealed that during the binding process of the 
inhibitor, the enzyme undergoes some conformational changes in the flap region 85.  The 
distance analysis amongst all the anticipated tip–tip distances of flap residues revealed the 
crucial role in mitigating the flap conformations.  The study provided a very insightful 
overview of the ligand binding process accommodated by rapid β-hairpin flap dynamics reliant 
on open and closed conformations. 
An integrated computational method, a two-layered ONIOM approach, developed by 
Morokuma and colleagues 86-89 has been used to study large molecular complex systems.  The 
ONIOM (our N-layered integrated molecular orbital plus molecular mechanics) approach is a 
hybrid method known to combine different QM method as well as MM method for large 
systems to provide accurate calculations.  The LdtMt2 is a very large enzyme which requires 
hybrid methods to be studied when complexed with inhibitors.  We proceeded with a two-
layered ONIOM method to investigate the binding interaction energies for FDA approved 
carbapenems against LdtMt2 enzyme.  Furthermore, the inclusion and the role of explicit water 
molecules confined in the active site of LdtMt2 was also investigated to ascertain the nature of 
binding interaction energies for carbapenems. 
  
14 
 
1.2 Computational background  
Computational chemistry is a fast-growing branch of chemistry intended to investigate 
chemical and biochemical challenges at an atomic and molecular aspect using theoretical 
methods encompassed in computer programs.  Computational chemistry has been significantly 
useful in studying chemical biological systems with an aim of acquiring adequate insight about 
macromolecular targets to help design novel drugs based on fundamental information of 
targets.  There are various theoretical methods in computational chemistry, namely, QM, MM 
and MD that are routinely used to study the chemical behaviour of molecular systems 90.   
1.2.1 Quantum Mechanics 
In the early 1920s Max Born and colleagues minted the term “quantum mechanics” which later 
appeared for the first time in Born’s paper titled "Zur Quantenmechanik" in 1924 91. Quantum 
mechanics is a branch of physics that deals with physical states of matter and the chemical 
behaviour of molecular systems on the scale of atoms and subatomic particles and has gained 
momentum in diverse fields of science. 
1.2.1.1 Ab-initio methods 
Ab-initio methods form part of quantum chemistry and is the most commonly used electronic 
structure method in both theoretical and computational chemistry.  Despite the method being 
the most accurate, its calculations are very expensive in terms of time and computational 
resources 92, 93.  These methods are guided by the principles of quantum mechanics derived 
from theoretical chemical theory and can produce very high accuracy given the suitable large 
basis set are used.  The distinct levels of theory for instance of Moller-Plesset (MPn) includes 
the effect of electron correlation, Hartree-Fock (HF) and Configuration Interaction (CI) 92.   
1.2.1.2 Density functional theory 
Kohn Hohenberg and Kohn Sham initiated a different quantum mechanical modelling method, 
density functional theory (DFT), that uses density functional models intended to improve the 
electronic structures by using electron density instead of wave function 94 to evaluate structural 
energies at ground state 94-96.  DFT operates by two fundamental useful theorems proposed by 
its inventors which uses electron density functional to explore the electronic structures of the 
systems 94.  The first theorem demonstrates that the ground state properties of complex-
electronic systems are unique functional of electron density that relies on 3-dimensional 
coordinates.  The second theorem states that the functional of the system that transmit the 
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ground state energy delivers the lowest energy dependent on the real input of the ground state 
density 95.  The Becke3LYP 97 correlation functional using designated basis set is known for 
its accuracy and relatively little computational cost 98.  A basis set is defined as a set of 
functions used to denote the electronic wave function in Hatree-Fock method or density 
functional theory for effective approximation of atoms in molecules.  The hybrid model 
Becke3LYP is frequently used for organic compounds and yield good geometries for 
molecular, organic and organometallic compounds 99. 
1.2.1.3 Semi-empirical methods 
Semi-empirical methods are represented by their use of empirically derived parameters for 
simplifying the approximation of the Schrodinger equation 100.  This method is based on the 
Hatree-Fock method that acknowledges the correlation effect of the method and is mostly 
applied on large molecular systems 93.  Semi-empirical methods only employ QM calculations 
specifically for the valence electrons in the system.  The most commonly used  functionals for 
semi-empirical methods are AM1, PM3, PM6, ZINDO and INDO 100.  These diverse 
functionals use experimental data and lower the computational cost by reducing the integrals 
for approximation of results. 
1.2.2 Molecular mechanics  
Molecular mechanics applies principles of classical mechanics to model molecular systems and 
it is mostly used to study varying molecular systems in terms of size and complexity to predict 
their relative potential energies using force fields and their quality of parameterization 101.  The 
empirical force field method utilizes classical mechanics with the perception that the total steric 
energy of the structure relies on the sum of complex interactions.  
MM methods typically have lower accuracy and are relatively less expensive than quantum 
mechanical methods in terms of computational resources 101, 102.  The major detriment of 
molecular mechanic methods is that the quality of the calculations is enormously reliant on 
empirical parameters.  The experimental studies or high-level of ab initio calculations normally 
determines the parameters based on the small number of model systems 102.  The most well-
known force fields include; Merk Molecular Force Field (MMFF) 103, AMBER 104, 105and 
Universal Force Field (UFF) 106.  In our case, the AMBER force field 104 was applied and it 
utilizes a simple harmonic model that features torsions, bond stretch and angle bends, and 
standard functions for Van der Waal and electrostatic interactions 107. These force-fields were 
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significantly designed for certain families of compounds and the researchers should ensure the 
suitability of the force-field for the proposed model system under investigation.  
1.2.3 ONIOM hybrid method (QM/MM) 
ONIOM (our own n-layered Integrated molecular Orbital and molecular Mechanics) is an 
onion-scale-like method that combines QM and MM methods in multiple layers 88, 108.  The 
ONIOM  hybrid method was first developed by Morokuma et al. 87, 109 to investigate small and 
large molecular systems.  In this method, the results are combined to predict the high-level 
calculation for the real system which is quite expensive.  ONIOM is applicable for geometry 
optimizations, calculation of energies and vibrational frequencies for complex molecular 
systems 87.  The ONIOM approach sufficiently provides accurate calculations for molecular 
systems, treated at three distinct levels (or layers) of theory, namely: low, medium and high 
layer.  The low layer encompasses the entire system and, in most cases, is evaluated with an 
inexpensive method such as a MM method.  Geometry optimization calculations of the 
partitioned system treated with diverse levels of theory in separate regions, the model system 
being in QM and the real system (larger region) treated by MM become easier 110.  The middle 
layer, also known as the intermediate model region, normally is considered in the case of a 
three-layered ONIOM model and often constitute of a portion larger than that of model system 
(high layer).  The high layer comprises of a smaller region, the model system, usually treated 
with the precisely accurate QM method, DFT109.  In our two-layered ONIOM hybrid method 
the catalytic residues (, His187, Ser188 and Cys205) as well as the carbapenem inhibitors were 
treated at high layer with DFT and the remaining part of the system at low layer with AMBER 
force field 104, 105.   
For a two-layered ONIOM model system, the calculations were performed with the following 
schemes:  
𝐸𝑂𝑁𝐼𝑂𝑀 = 𝐸𝑟𝑒𝑎𝑙 𝑙𝑜𝑤 +  𝐸𝑚𝑜𝑑𝑒𝑙 ℎ𝑖𝑔ℎ −  𝐸𝑚𝑜𝑑𝑒𝑙,𝑙𝑜𝑤 (𝟏) 
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1.2.3.1 ONIOM binding free energy calculations 
For ONIOM calculations the versatile pre-and post-processor graphical user interface (GUI) 
111, Gauss View program, implemented in Gaussian 09 112 package was used to model, view 
and prepare the input files for all the enzyme-inhibitor complexes.  The binding free energies 
of the four selected FDA approved carbapenems were investigated for LdtMt2 using Gauss view 
program and ONIOM model implemented in Gaussian 09 112 package: ONIOM (B3LYP/6-
31G(d): AMBER).  The ONIOM binding interaction energy can be calculated as follow: 
∆𝐺𝑂𝑁𝐼𝑂𝑀 ≈ ∆𝐺 = 𝐺𝑐𝑜𝑚𝑝𝑙𝑒𝑥 − (𝐺𝑝𝑟𝑜𝑡𝑒𝑖𝑛 + 𝐺𝑙𝑖𝑔𝑎𝑛𝑑)(𝟐) 
Where, ΔG denotes the total binding energy of the system, Gcomplex is the energy of complex 
(enzyme + ligand) and Gprotein and Gligand are the energies obtained individually from the 
enzyme and ligand respectively.  The details of the computational methods are presented in the 
respective chapters. 
1.3 Aim and Objectives 
This study has two aims: 
1. To generate a computational chemistry model using a two-layered ONIOM method and 
to calculate the binding interaction energies between carbapenems and LdtMt2 from 
Mycobacterium tuberculosis.  To achieve this, the following objectives were outlined: 
➢ To determine the binding free energies of carbapenems against LdtMt2 during 
the complexation process using a DFT-B3LYP functional in a two-layered 
ONIOM method. 
➢ To determine the topological properties of the carbapenem-LdtMt2 complexes 
using AIM200 software. 
➢ To determine the intermolecular interactions by second perturbation theory 
using NBO analysis approach. 
2. To examine using an ONIOM computational model with explicit water molecule 
confined in the active site to ascertain the nature of binding interaction energies of 
carbapenems. To achieve this, the following objectives were outlined: 
➢ To evaluate the role of water molecule in the binding interface of carbapenems 
and LdtMt2 using a DFT-B3LYP functional with 6-31+G(d) basis set. 
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➢ To determine the binding free energies of carbapenem—water—LdtMt2 
complexes. 
➢ To determine the binding features of carbapenems in a water mediated LdtMt2 
complexes using Ligand scout. 
➢ To determine the topological properties of the carbapenem—water—LdtMt2 
complexes using AIM200 software. 
➢ To determine the intermolecular interactions of carbapenem—water—LdtMt2 
complexes by second perturbation theory using NBO analysis approach. 
1.4 Thesis outline  
This project evaluated the potential of the computational chemistry method, ONIOM 
(QM/MM), as an appropriate method for studying large systems. Chapter 2 outlines the use 
of an integrated two-layered ONIOM method for determination of binding interaction energies 
of carbapenems against LdtMt2.  Chapter 3 outlines the exploitation of the ONIOM 
computational model with explicit water molecule confined in the active site of L, D 
transpeptidase 2 to ascertain the nature of binding interaction energies of carbapenems.  
Chapter 4 presents the conclusion and significance of the study.  
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Abstract  
Tuberculosis remains a dreadful disease that has claimed many human lives worldwide.  
Elimination of the causative agent mycobacterium tuberculosis remains elusive.  Multidrug-
resistant TB is rapidly increasing worldwide; therefore, there is an urgent need for improving 
the current antibiotics and novel drug targets to successfully curb the TB burden.  L, D-
transpeptidase 2 is an essential protein in Mtb that is responsible for virulence and growth 
during the chronic stage of the disease.  Both D, D- and L, D-transpeptidases need to be 
inhibited concurrently to eradicate the bacterium.  It was recently discovered that classic 
penicillins only inhibit D, D-transpeptidases, while L, D transpeptidases are blocked by 
carbapenems.  This has contributed to drug resistance and persistence of tuberculosis.  Herein, 
a hybrid two-layered ONIOM (B3LYP/6-31G+(d):AMBER) model was used to extensively 
investigate the binding interactions of LdtMt2 complexed with four carbapenems (biapenem, 
imipenem, meropenem, and tebipenem) to ascertain molecular insight of the drug-enzyme 
complexation event.  In the studied complexes, the carbapenems together with catalytic triad 
active site residues of LdtMt2 (His187, Ser188 and Cys205) were treated at with QM [B3LYP/6-
31+G(d)], while the remaining part of the complexes were treated at MM level (AMBER force 
field).  The resulting Gibbs free energy (G), enthalpy (H) and entropy (S) for all complexes 
showed that the carbapenems exhibit reasonable binding interactions towards LdtMt2.  
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Increasing the number of amino acid residues that form hydrogen bond interactions in the QM 
layer showed significant impact in binding interaction energy differences and the binding 
stabilities of the carbapenems inside the active pocket of LdtMt2.  The theoretical binding free 
energies obtained in this study reflect the same trend of the experimental results.  The 
electrostatic, hydrogen bond and Van der Waals interactions between the carbapenems and 
LdtMt2 were also assessed.  To further examine the nature of intermolecular interactions for 
carbapenem-LdtMt2 complexes, AIM and NBO analysis were performed for the QM region 
(carbapenems and the active residues of LdtMt2) of the complexes.  These analyses revealed 
that the hydrogen bond interactions and charge transfer from the bonding to anti-bonding 
orbitals enhances the binding and stability of carbapenem-LdtMt2 complexes. 
Keywords: Tuberculosis (TB); Mycobacterium tuberculosis (Mtb); L, D-transpeptidase 2 
(LdtMt2); Carbapenems; Our Own N-layered Integrated Molecular Orbital and Molecular 
Mechanics (ONIOM); Quantum theory of atoms in molecules (QTAIM); Natural bond orbital 
(NBO). 
1.0 Introduction  
Tuberculosis is an infectious disease caused by mycobacterium tuberculosis bacilli that 
threatens many lives worldwide.  Despite the advanced efforts made to improve TB treatment, 
the eradication of the disease is still an enormous challenge.  Recent statistics from the World 
Health Organisation (WHO) reveal that about 10.4 million new TB cases were reported in 
20161.  The growing incidences of multi-drug resistant (MDR-TB) and extensively drug-
resistant (XDR-TB) strains of mycobacterium tuberculosis complicates the treatment regimens 
currently available thus threatening a return to a pre-antibiotic era2, 3. 
The upsurge of resistance to currently available anti-TB therapeutics leads to rapid 
dissemination of the infection.  In South Africa, the incident cases of MDR and XDR continue 
to be a leading burden to public health care, as the disease remains the foremost cause of death4.  
For HIV patients, South Africa has the highest TB burden amongst 22 Sub-Saharan countries 
and has the highest figures of HIV-infected people suffering from TB, which contributes to 
high incidence cases of multi-drug resistant tuberculosis5.  In the light of this fact, development 
of novel anti-tubercular therapeutic agents is urgently required6.   
The peptidoglycan moiety of Mtb involves 4→3 and 3→3 peptide cross-links facilitated by D, 
D-transpeptidase and L, D-transpeptidase (LDT) enzymes, respectively.  Disruption of 
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peptidoglycan biosynthesis and cross-linking requires complete inhibition of both 
transpeptidases which subsequently kills the bacteria6, 7.  Most bacterial species possess 
approximately less than 10% of 3→3 cross-linkages catalysed by LDTs during the exponential 
and stationary phase of growth.  Mtb is the only known mycobacterium that demonstrates a 
high content of 3→3 crosslinks (80%) making this enzyme family an attractive target8-10. 
Carbapenems are a well-known class of β-lactam antimicrobial agents with reported inhibitory 
properties against different transpeptidases8, 11, 12.  In particular, carbapenem derivatives are 
known as effective compounds against L, D-transpeptidase 2 from mycobacterium 
tuberculosis8, 9.  This enzyme has thus been identified by various researchers as a possible 
target for TB inhibition9, 10, 13-17.  Erdemli et al.,9 established that L, D-transpeptidase 2 (LdtMt2), 
is the product of gene MT2594 in Mtb.  A Mtb strain lacking LdtMt2 leads to alteration of colony 
morphology, loss of virulence and enhanced susceptibility to amoxicillin–clavulanate during 
the chronic phase of infection.  Therefore, LdtMt2 is vital for the physiology of the 
peptidoglycan and is essential for the virulence of Mtb6, 9, 18.  Catalysis occurs at the active site 
(residues Cys354, His336, and Ser337) of LdtMt2 and involves two reaction steps namely, 
acylation and deacylation9.  In this proposed mechanism, a proton (R-SH) transfer occurs from 
Cys354 to the His336 followed by a nucleophilic attack (R-S
-
) on the carbonyl group of the 
substrate by the sulfur of Cys354.  However, the presence of His352 and Asn356 residues 
provides the possibility of hydrogen bond formation and hydrophobic interactions which can 
stabilize the enzyme-inhibitor complex.  The carbapenems’ thio-side chain can also be 
potentially tailored to accommodate the protein surface and to optimize inhibition of LdtMt2.  
In addition, earlier experimental observations reconfirmed that the thio-side chain of the 
carbapenem derivatives fulfils an important role to optimize the inhibitor efficiency by forming 
critical hydrogen bonds inside the active site pocket18. 
Besides several publications in the field of computer-aided drug discovery for the potential 
anti-HIV agents made by our research group19-21, the theoretical binding free energies of the 
commercially available inhibitors against LdtMt2  were also reported using MM-GBSA and 
solvation interaction energy (SIE) methods22.  The role of LdtMt2 flap opening and closing upon 
complexation of the substrate and three carbapenems, namely: ertapenem, imipenem and 
meropenem, was also reported using 140 ns molecular dynamics simulation with explicit water 
solvent23.  The determined binding affinities showed more favorable free binding energies for 
ertapenem and meropenem than imipenem in the closed conformation of the β-hairpin flap23.  
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Despite several studies in this field, to the best of our knowledge, limited attention has been 
paid to the inhibition mechanism of LdtMt2 using carbapenem derivatives. 
The n-layered integrated molecular orbital and molecular mechanics (ONIOM)24-28 method is 
a hybrid QM/MM technique used to compute interaction energies using the combination of 
quantum mechanical method (QM) with a molecular mechanics (MM) force field29, 30.  This 
multi-layered method is utilized mostly in large biosystems where the model and real system 
are consistently treated with accurate level of theories24-28.  In this approach, the active residues 
and ligand are treated with a high level of theory (Density Functional Theory or ab initio) while 
the remaining part of the system is treated at a lower level (AMBER force field)31-34. 
In this study, the molecular orbital calculations were performed for four selected FDA-
approved carbapenems (biapenem, imipenem, meropenem, and tebipenem) complexed to 
LdtMt2 using a two-layer ONIOM (QM:MM) approach.  Structures of the carbapenems for the 
present work are presented in Figure 1.  
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Figure 1.  The structures of the selected FDA approved carbapenems that are active against L, 
D transpeptidase 2.  
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For further analysis of the calculated ONIOM binding free energies, we investigated the 
electrostatic and hydrogen bonding interactions for these inhibitor-enzyme complexes.  For 
further analysis of the intermolecular interactions between LdtMt2 and the selected 
carbapenems, QTAIM35 and NBO36 analysis were performed on the QM region of the 
biosystems (carbapenems and the active residues of LdtMt2).  The AIM topological indices 
assessed the nature of hydrogen bond interactions through molecular orbital interactions and 
NBO analysis determined the electron charge transfer between carbapenems and the active 
residues of LdtMt2.  Our hypothesis is that this computational study will provide a greater level 
of insight into the crucial interactions of the inhibitor during complexation.  This in turn, will 
be useful for the design of novel and more potent anti-TB drugs from carbapenem inhibitors.   
2.0 Material and Methods 
2.1 System preparation  
The enzyme-inhibitor complex structures of M.tb LdtMt2 were prepared by superimposing 
Chain A of 3TUR9 complexed with the natural substrate and 3VYP37 meropenem-bound 
complex.  The covalently bound meropenem from 3VYP was restored by deletion of the 
covalent bond between the sulfur atom of cysteine residue and the carbonyl carbon of β-lactam 
ring.  The β-lactam ring was restored, and the hydrogen atoms were added and optimized.  This 
complexed structure was then used as a reference to model other complexes by superimposing 
other inhibitors into the same geometry using PyMOL38. 
A molecular dynamics (MD) calculation was performed on the starting complex to affix the 
missing protons using X-leap39 software.  The MD simulations were carried out using Amber 
14 with the ff99SB40 force field (for proteins) and GAFF41 for the inhibitors.  The complexes 
were solvated with TIP3P42 explicit water in a cubic box with 10 Å distance and counterions 
were added to neutralize the complexes.  Partial Mesh Ewald (PME)43 method was applied for 
long range electrostatic forces with cut-off of 12 Å.  All bonds to hydrogen atoms was 
constrained using the SHAKE algorithm.44  Two-stage geometric minimization was performed 
by 2500 steps of steepest decent minimization followed by 2500 of conjugated gradient to 
remove clashes and bad contacts.  To accurately assign the protonation states of the residues in 
the enzyme at pH=7.8, the empirical PropKa web server45 was used.   
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The prepared complexes were then subjected for ONIOM24-28 calculations.  The ONIOM input 
files together with the optimized output files of all complexes are provided in PDB format with 
the supplementary materials. 
2.2 ONIOM hybrid (QM:MM) method  
All the calculations were performed using the Gaussian0946 program.  It was established in 
numerous studies47-49 that the Becke3LYP51, 52 functional yields energies in good agreement 
with high-level ab initio methods.  The two-layered ONIOM24, 25, 50 hybrid approach 
(B3LYP/6-31+G (d): AMBER) invented by Morokuma et al.,29 was employed to assess the 
binding affinities within the selected carbapenem-LdtMt2 complexes.  In this ONIOM
24-28 
model, the catalytic active residues of the LdtMt2 enzyme (His187, Ser188 and Cys205) and the 
selected FDA-approved inhibitors were modeled using density functional theory (DFT)51, 52, 
B3LYP53, 54 functional and the 6-31+G(d)55, 56 basis set.  The remaining part of the enzyme was 
kept at the low level of theory (MM)26, 57 with an AMBER force field. 
A full geometry optimization was performed for the selected carbapenem-LdtMt2 complexes.  
Normal mode frequency analyses were performed at the same level of theory to examine the 
nature of stationary points to be in real minimum potential energy surface with no negative 
frequency.  The total interaction energies are defined as:  
∆𝐸𝑂𝑁𝐼𝑂𝑀 = ∆𝐸𝑚𝑜𝑑𝑒𝑙,ℎ𝑖𝑔ℎ +  ∆𝐸𝑟𝑒𝑎𝑙,𝑙𝑜𝑤 −  ∆𝐸𝑚𝑜𝑑𝑒𝑙,𝑙𝑜𝑤                                                       (𝟏) 
Where, ∆Emodel denote the energies of the model system defined at high and low level of theory 
and ∆Ereal denote the whole (real) system.  Thus, the equivalent binding interaction ONIOM 
energies of the complex systems are determined as follows: 
∆𝐺𝑂𝑁𝐼𝑂𝑀 ≈ ∆𝐺 = 𝐺𝑐𝑎𝑟𝑏𝑎𝑝𝑒𝑛𝑒𝑚―LdtMt2 – (𝐺carbapenem + 𝐺LdtMt2 )                                    (𝟐) 
The thermodynamic quantities (enthalpies and entropies and it different entropic contributions) 
were also attained from frequency calculations.  The different entropic contributions (rotation, 
translation, and vibration) for carbapenem-LdtMt2 complexes were calculated as follows:  
∆𝑆𝑡𝑜𝑡𝑎𝑙 = ∆𝑆𝑐𝑎𝑟𝑏𝑎𝑝𝑒𝑛𝑒𝑚―LdtMt2 − (∆𝑆𝑐𝑎𝑟𝑏𝑎𝑝𝑒𝑛𝑒𝑚𝑠 + ∆𝑆LdtMt2)                                     (𝟑) 
2.3 Mode of interactions and hydrogen-bond analysis  
The LigPlot58 program generated the 2-D representation of protein-ligand complexes from the 
output file of the PDB input file.  This program gives an informative representation of 
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intermolecular interactions (hydrogen bond and hydrophobic interactions) that exist between 
the protein and the ligand.  The hydrogen bonds59-61 and hydrophobic interactions for eight 
selected carbapenem-LdtMt2  complexes were analysed using LigPlot
58.  The hydrogen bond 
distances between the carbapenems and LdtMt2  in the complexes were determined using 
Discovery Studio62 to attain the proximity of cysteine towards the β-lactam’s carbonyl group.  
This is essential for determining the binding mode of carbapenems interacting with LdtMt2 and 
to provide the best inhibitor pose relative to the catalytic residues. 
2.4 QTAIM calculations 
The quantum theory of atoms in molecules (QTAIM) invented by Bader63 is a theoretical tool 
that enables hydrogen bond analysis.  The hydrogen bonds (HB) between a hydrogen donor 
and acceptor groups are connected by a Bond Critical Point (BCP).  The basis of the theory is 
fundamentally reliant on the critical points (CPs) of the molecular electronic charge density 
ρ(r).  The critical points are described by three eigenvalues of Hessian matrix (λ1, λ2, and λ3) 
based on the molecular electronic charge densities.  Popelier and Bader64 used the AIM analysis 
to characterize the significance of chemical interactions that strictly involves the hydrogen 
bonding between clustered systems64.  The two measures are proposed, electron density ρ(r) 
and the Laplacian of the electron density ∇2 ρ(r), assessed at the BCP of two hydrogen bonded 
atoms.  The location of BCP strongly relies on the electronegativities of the interacting atoms 
in molecules.  Another important parameter is the bond ellipticity (ε), defined as follows: 
𝜀 = [(
𝜆1
𝜆2
) − 1]                                                                                                                                     (𝟒)   
Where λ1 and λ2 are perpendicular curvatures of the density at the BCP described by the large 
values of electron density.  The ellipticity provides a significant measure of π-bond nature and 
delocalization of the electronic charge and determines the bond stability.   
2.5 Natural bond orbital (NBO) 
The natural bond orbital (NBO) analysis36 is an appropriate method used to study the effect of 
electron charge transfer between QM region of LdtMt2  and carbapenems using the second 
perturbation theory of NBO analysis using NBO3.1 program implemented in Gaussian 09 
software46.  The NBO analysis was achieved based on the molecular wave functions distorted 
into one-centre (lone pair) and two centres (bond) representations.  The Fock matrix diagonal 
elements in the NBO depiction represent the energies for localized bonds, lone pairs, and anti-
32 
 
bonds of the studied systems.  The stabilization energy E (2) associated with i → j delocalization 
is explicitly estimated by the following equation: 
𝐸(2) = ∆𝐸𝑖𝑗 = 𝑞𝑖
𝐹(𝑖,𝑗)2
𝜀𝑗−𝜀𝑖
         (5) 
Where qi denotes the ith donor orbital occupancy, εi, and εj are the diagonal elements (orbital 
energies) and F (i, j) is the off-diagonal element, respectively, associated with the NBO Fock 
matrix.  The higher the value of E (2), the more charge transfer between electron donors and 
electron acceptors36. 
3.0 Results and Discussion  
During geometry optimization it was observed that the two carbapenems experienced slight 
movement inside the binding site of LdtMt2  (Figure 2) as expected
22.  The short-range distances 
between the sulfur atom of the catalytic cysteine residue and the carbonyl carbon of the β-
lactam ring of the carbapenem were in the range of 3.550 Å to 3.942 Å. 
Figure 2.  3D-structure of A. Imi―LdtMt2 and B. Mero―LdtMt2 complexes, the inhibitor is 
presented as wireframe and the considered active pocket residues as ball and stick (Figure 3S).  
The ONIOM (Gaussian) input files as well as the optimized output files of all 
inhibitor―enzyme complexes are also provided with the supplementary material. 
The superimposed 3D structures of 3TUR (LdtMt2 in complex with peptidoglycan fragment as 
natural substrate) and 3VYP (meropenem―LdtMt2 adduct), as well as other superimposed 
complexes are presented in Figures 1S and 2S (Supplementary material). 
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ONIOM interaction energies  
A descriptive illustration of our ONIOM model is shown in Figure 3, where the carbapenems 
and the catalytic residues of LdtMt2 were treated at QM (B3LYP/6-31+G(d)) level and the 
remaining part of the complexes was treated at MM level (AMBER force field).   
 
Figure 3.  A two-layered QM:MM ONIOM (B3LYP/6-31G+(d): AMBER) model of Bia-
LdtMt2 complex.  Active site residues His187, Ser188 and Cys205 were also treated at the same 
QM level.  The ONIOM (Gaussian) input files as well as the optimized output files of all 
inhibitor-enzyme complexes are also provided with the supplementary material (Figure 4S). 
To assess the binding affinities of the selected carbapenems against LdtMt2 using the ONIOM 
method, we included the three catalytic triad residues (Cys205, His187, Ser188) of LdtMt2 and 
carbapenems at QM level of theory (Table 1).  After that, two more residues (His203 and 
Asn207), found to be in close contact with the carbapenems, were also included at the QM 
level (Table 1S) to ascertain the fundamental role they have in thermodynamic properties. 
As for the comparison of our two applied ONIOM models, the first model with three active 
site residues (His187, Ser188 and Cys205) treated at the QM level of theory exhibited less 
negative theoretical binding free energies (Table 1) in comparison to the second model with 
five active site residues (His187, Ser188, His203, Cys205 and Asn207) (Table 1S).  
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The fist model followed the experimental trend, while the second model, with five catalytic 
residues at the QM level, the binding energy trend for tebipenem and imipenem was reversed 
(Table 1S). 
The selected carbapenems possess a common thiol-group with varying side chains that 
distinguish them from each other.  The side chains are said to play an integral role in stabilizing 
the complex by forming electrostatic and van der Waals interactions during the binding 
process. 
Table 1.  The binding free energies (kcal mol-1) for FDA-approved carbapenem-LdtMt2 
complexes evaluated using ONIOM (B3LYP/6-31+G (d): AMBER).  [reported experimental 
data9, 65 and calculated theoretical results] 
Gibb’s free energy (G), Enthalpies (H), Entropies (S) and entropic contribution, translational (Strans), 
rotational (Srot), vibrational (Svib) are derived from equations 2 and 3.  The ONIOM (Gaussian) input files as 
well as the optimized output files of all inhibitor―enzyme complexes are also provided with the supplementary 
material. 
Our group previously reported a longer MD (140 ns) simulation study that aimed to investigate 
the role of flap dynamics during the binding process of the natural substrate as well as three 
carbapenems23.  Their results for the carbapenem-LdtMt2 complexes, namely; Mero-LdtMt2 , 
Erta-LdtMt2, and Imi-LdtMt2  gave binding free energies (Gbind) of; -40.42 kcal mol
-1, -37.91 
kcal mol-1 and -34.47 kcal mol-1, respectively23.  In contrast to that, the experimental binding 
energy trend for Mero-LdtMt2 and Imi-LdtMt2 is reversed (there is no reported value for 
ertapenem).  Therefore, to further improve the model for these inhibitor-enzyme complexes, a 
hybrid two layered ONIOM approach was chosen to explore the non-covalent binding 
interaction energies as another method to investigate the pre-complex stability prior to 
carbapenems binding. 
It was noted that for Imi-LdtMt2  and Mero-LdtMt2  complexes, the theoretical order of Gibb’s 
binding free energies varied to that of our previous study23.  The theoretical Gibb’s free energies 
(G) for carbapems-LdtMt2 complexes range from -23.88 to -14.89 kcal mol
-1.  However, Imi-
Complexes Gbind(Exp) 
kcal mol-1 
Gbind(Calc) 
kcal mol-1 
H 
 kcal mol-1 
STotal   
cal mol-1 K-1 
Strans 
cal mol-1 K-1 
Srot 
cal mol-1 K-1 
Svib 
cal mol-1 K-1 
Imi-LdtMt2  -9.82 -23.88 -43.58 -66.08 -42.95 -34.78 11.65 
Tebi-LdtMt2  -9.35 -23.80 -42.49 -62.67 -43.68 -36.25 17.26 
Bia-LdtMt2  -8.96 -23.18 -44.06 -70.03 -43.43 -35.48 8.88 
Mero-LdtMt2  -8.16 -14.89 -41.86 -91.64 -43.68 -35.99 -11.97 
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LdtMt2, Tebi-LdtMt2 and Bia-LdtMt2 have comparable Gibb’s free energies G (-23.88 kcal mol
-
1, -23.80 kcal mol-1 and -23.18 kcal mol-1, respectively) with a discrepancy of 0.08─0.7 kcal 
mol-1 and the relative energy differences are in good agreement with experimental data (Table 
1).  Even though Mero-LdtMt2 complex shows the lowest binding energy for both experimental 
and theoretical results, the calculated theoretical results display larger relative differences 
compared to the experimental results. 
The enthalpy contribution (H) for carbapenem-LdtMt2 complexes ranges from -44.06 to -41.86 
kcal mol-1.  This indicates that the non-covalent complexation process is exothermic.  The 
enthalpy contribution (∆H) of Bia-LdtMt2 and Imi-LdtMt2 complexes is -44.06 kcal mol
-1 and -
43.58 kcal mol-1 respectively and are comparable.  Moreover, the enthalpy contribution (∆H) 
for all complexes are slightly similar (Table 1).  Finally, the Mero-LdtMt2 complex has the 
weakest enthalpy contribution of ∆H= -41.86 kcal mol-1, which contributes to the weak 
calculated binding free energy (∆G = -14.89 kcal mol-1). 
In the case of entropy contribution (S), it was noted that Mero-LdtMt2 shows the most negative 
entropy ∆S = -91.64 cal mol-1 K-1.  The higher entropy signifies reduced degrees of freedom of 
the inhibitors in the protein active pocket.  This contributes to the less favourable binding free 
energy for meropenem.  Bia-LdtMt2 exhibits a negative entropy of ∆S = -70.03 cal mol
-1 K-1, 
while that of Imi-LdtMt2 is -66.08 cal mol
-1 K-1 and Tebi-LdtMt2, with the most favourable entropy 
response at -62.67 cal mol-1 K-1.   This overcomes its smaller enthalpy value rendering it the 
second highest in Gibb’s binding energy. Additionally, among the entropy components, the 
translational (Strans) and rotational (Srot) values for all considered complexes are in close 
range, while the vibrational entropies (Svib) differs significantly in all complexes and this 
could be attributed to the thio-side chain of each considered carbapenem.  Mero-LdtMt2 is the 
only complex that displays a negative vibrational entropy with contributes significantly to the 
overall entropy value.   
Hydrogen bonding interactions 
The fundamental role of hydrogen bonds in target-drug affinities has been significantly 
explored59, 66, 67.  Moreover, protein conformation is driven by hydrogen bond formation, which 
thus optimizes hydrophobic interactions and leads to increased binding affinities of complex 
molecules59.  The van der Waals and electrostatic interactions in complexes are crucial for 
maintaining stability between protein-ligand arrays.  Hydrogen bond interactions serve a 
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significant role in stabilizing the inhibitor inside the binding pocket although these are 
considered as weak interactions68.  Structural analyses of the carbapenems show significant 
interactions with LdtMt2 amino acids (His203, Asn207, Ser202, Cys205, Thr201, His187, 
Thr171, Trp191, Ser192, and Tyr169) in the catalytic cavity.  In most cases, the hydroxyethyl 
substituent, carbonyl oxygen, and nitrogen of the carbapenem β-lactam ring are responsible for 
hydrogen bond formation.  In order to obtain more details and understanding of these 
interactions, the distances of hydrogen bonds between ligands and receptors were analysed 
with Discovery studio62 before and after optimization (Figure 4).  The measured intermolecular 
bond distances, for all the selected carbapenem-LdtMt2 complexes, between the sulfur atom of 
the catalytic cysteine and carbonyl carbon of the β-lactam ring were adequately in proximity 
for nucleophilic attack as expected.  It was observed that in all complexes, the average bond 
distance between the sulfur atom of cysteine and carbonyl carbon of the β-lactam ring had 
increased (after optimization) with a concomitant decrease in the distance from the hydroxyl 
hydrogen to the sulfur.  As a result, the carbonyl oxygen also participated in forming hydrogen 
bonds with the His203 and Asn207.  (See details shown in supplementary material Figure 5S.)  
 
Figure 4.  Schematic representation of hydrogen bond interactions and their respective 
distances (A) Before optimization (B) After optimization.  The ONIOM (Gaussian) input files 
as well as the optimized output files of all inhibitor-enzyme complexes are also provided with 
the supplementary material. 
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Hydrogen bond modes of interaction in carbapenem-LdtMt2 complexes  
To further examine the nature of the calculated binding free energies for the FDA approved 
inhibitors complexed with LdtMt2, the LigPlot
58 program was used to reveal the possible 
intermolecular hydrogen bond and electrostatic interactions between the carbapenem-LdtMt2  
complexes.  The critical amino acid residues such as His203, Asn207, Ser202, Cys205, Thr201, 
His187, Thr171, Trp191, Ser192, and Tyr169, (These correspond to His352, Asn356, Ser351, 
Cys354, Thr350, His336, Thr320, Trp340, Ser341, and Tyr318 of the original crystal 
structure), directly interact with the inhibitor by forming hydrogen bonds and hydrophobic 
interactions (Figure 5).  The details of other complexes are depicted in the supplementary 
materials (Figure 6S). 
Figure 5.  A 2-D schematic representation of hydrogen bond and hydrophobic interactions 
between catalytic amino acid residues and the carbapenems (A. Imipenem and B. Meropenem).  
Red dotted lines represent hydrogen bond interactions.  
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The plots show hydrogen bonding and electrostatic interactions occurring between the 
inhibitors and the catalytic active site residues of LdtMt2.  As it is observed, the arrangement of 
the catalytic amino acids residues displays a consistent pattern in proximity to the β-lactam ring 
of all the carbapenems. 
QTAIM analysis  
The quantum theory of atoms in molecules (QTAIM) has been used to characterize and 
quantify the H-bonding interactions for carbapenem-LdtMt2  complexes as described by Bader
63, 
69.  After geometry optimization of the carbapenem-LdtMt2 complexes using a two-layered 
ONIOM (B3LYP/6-31G+(d): AMBER) model, the QM region of carbapenem-LdtMt2 
complexes (catalytic triad residues: His187, Ser188, and Cys205 and the selected 
carbapenems), were truncated and the wave functions of the QM region were calculated using 
B3LYP/6-31G+(d).  Followed by the ab initio wave function calculations, the electron 
topography of carbapenem-LdtMt2  complexes were generated using AIM2000 software 
package70.  The topological analysis of the electron charge density provides the location of the 
critical points wherein the gradient of electron density is insignificant35.  The BCP, which 
determine the existence or non-existence of hydrogen bond interactions and the molecular 
graph to connect the bond paths of critical points of the studied truncated systems, were 
obtained.  The Imi-LdtMt2 and Mero-LdtMt2 complexes are shown in Figure 6.  In general, if a 
hydrogen bond does exist between two atoms, the range of ρ(r) and ∇2 ρ(r) are between 0.002–
0.035 a.u. and 0.024–0.139 a.u., respectively71.  The topological parameters for the truncated 
carbapenem-LdtMt2 complexes are tabulated in Table 2. 
According to Table 2, the ρ(r) and ∇2 ρ(r) values for carbapenem-LdtMt2 complexes vary in 
terms of their respective interacting atoms at specific critical points (CP).  However, the 
minimum and maximum for both the ρ(r) and ∇2 ρ(r) in all the studied carbapenem-LdtMt2 
complexes interactions are 0.0053─0.0245 and 0.0184─0.0594 a.u, respectively.  In this 
regard, Imi-LdtMt2, Tebi-LdtMt2 and Bia-LdtMt2 have comparable ρ(r) and ∇2 ρ(r) values that 
determine the strength of the hydrogen bond interactions and authenticate the existence of 
hydrogen bond formation at each BCP, represented by red dots in the molecular graph plot 
(Figure 6.).  It is noteworthy that the average values for ρ(r) and ∇2 ρ(r) of HB’s for each 
complex also corresponds to the theoretical and experimental Gibb’s binding free energies. 
The Laplacian of charge density at the bond critical point, ∇2 ρ(r), is defined as the sum of three 
preliminary curvatures of the function at each point of the space.  The sign of ∇2 ρ(r) serves an 
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integral role in the determination of whether the charge density is locally depleted ∇2 ρ(r)>0, 
or locally concentrated ∇2 ρ(r)<0.  Consequently, the standard measures of hydrogen bonds are 
characterized by H(r)<0 and ∇2 ρ(r)<0 for strong hydrogen bonds, whereas the medium 
hydrogen bonds with H(r)<0 and ∇2 ρ(r)>0, and H(r)>0, and ∇2 ρ(r)>0 are determined to be 
the weak ones72.  The observed phenomena in the case of ∇2 ρ(r) values in Table 2 appear 
positive while some of the values of H(r) appear negative.  This indicates that the bond nature 
is considered as being partially covalent-partially electrostatic (Pc-Pe)73.  The two parameters, 
∇2 ρ(r) and H(r) at BCP are normally used to categorize and characterize hydrogen bonds.  
Distance analysis is another crucial factor in determining the bond strength between interacting 
atoms induced by electronegativity because of electron charge density. 
Table 2.  AIM topological parameters including electron density (ρ) and their Laplacian of electron 
density (▽2ρ) in a.u. and energetic parameters G(r), H(r), and V(r) in (kcal/mol) in carbapenem-LdtMt2 
complexes calculated at the B3LYP/6-31+G(d).  
KEG, Lagrangian kinetic energy density G(r), KEK, Hamiltonian kinetic energy density H(r), VIR, Virial filed 
function V(r). 
  
Hydrogen 
bonds 
Complexes 
interactions 
ρ (r) ▽2ρ (r) G(r) H(r) V(r) Ellipticity (ε) 
 Imi-LdtMt2        
HB1 O56H···S36 0.0232 0.0574 0.0154 0.0010 0.0164 0.0359 
HB2 C55H···C11 0.0053 0.0184 0.0034 -0.0012 0.0022 0.6362 
 Tebi-LdtMt2        
HB1 O81H···S36 0.0230 0.0565 0.0151 0.0010 0.0161 0.0370 
HB2 C80H···C11 0.0069 0.0233 0.0045 -0.0013 0.0031 0.1980 
 Bia-LdtMt2        
HB1 O76H···S70 0.0233 0.0569 0.0153 0.0011 0.0163 0.0388 
HB2 C75H···C45 0.0072 0.0245 0.0047 -0.0014 0.0033 0.1500 
 Mero-LdtMt2        
HB1 O86H···S81 0.0245 0.0594 0.0161 0.0013 0.0175 0.0393 
HB2 C85H···C56N 0.0080 0.0275 0.0054 -0.0015 0.0039 0.1495 
40 
 
The ellipticity (ε) values of each bond critical point for all carbapenem-LdtMt2 complexes are 
reported in Table 2.  Ellipticity is the important measure of the bond's stability i.e. high 
ellipticity value signifies unstable bonds.74  The ellipticity of the carbapenem-LdtMt2 complexes 
ranges from 0.0359─0.6362 a.u.  It is noted that HB1 is dominant for all complexes.  The ε 
values for HB1 also follow the same trend of the binding free energies (experimental and 
theoretical).  It is worth pointing out that the hydrogen bonds in the QM region of all 
carbapenem-complexes demonstrate stable electrostatic interactions, considering the average 
amount of ellipticity as Imi—LdtMt2 > Tebi—LdtMt2 > Bia—LdtMt2 ≈ Mero—LdtMt2 and this 
trend is consistent with the obtained binding free energies. 
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Figure 6.  Molecular graph of A. Imi-LdtMt2 and B. Mero-LdtMt2 complexes generated using 
AIM2000 software.  Small red spheres and lines correspond to the bond critical points (BCP) 
and the bond paths, respectively.  See details of the molecular graph for other complexes in 
Figure 7S. 
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Natural Bond Orbital analysis 
In the NBO analysis36, electronic wave functions are elucidated in terms of a set of occupied 
Lewis and a set of unoccupied non-Lewis localized orbitals.  The delocalization effect can be 
recognized by the existence of off-diagonal elements of the Fock matrix.  The intensities of 
delocalization interactions are predicted by the second-order perturbation theory E (2)36.  Based 
on the optimized ground state geometries of the QM region of the carbapenem-LdtMt2 
complexes using the B3LYP/6-311+G(d), the NBO analysis of donor-acceptor (bond-anti-
bonding) interactions have been assessed.  The HB1 is also dominant in all complexes.  The 
stabilization energies associated with delocalization of electrons is the strongest in S36···· 
O56─H73 (HB1) of the Imi-LdtMt2 complex by 15.80 kcal mol
-1.  In the Mero-LdtMt2 complex, 
the S81····O86─H87 (HB1) have the strongest stabilization energy of 17.45 kcal mol-1 as 
shown in Table 3. 
The other carbapenem-LdtMt2 complexes (Tebi-LdtMt2 and Bia-LdtMt2) also exhibited the 
strongest stabilization energies in HB1 interactions.  This observation reveals that even for the 
complexes with moderate and weak binding affinities, electron charge transfer will still occur 
from donor to acceptor units (Table 3).  The charge transfer between the lone pair (LP) and the 
anti-bonding (BD*) orbitals, as shown in Figure 7, exhibit larger stabilization E2 values.  As a 
result, this indicates the possibility of electron charge transfer from donors to acceptors.  The 
formation of hydrogen bonds provides sufficient evidence for the considerable electron charge 
transfer from the lone pair orbital to anti-bonding orbital.  Hence, the NBO analysis agrees with 
the QTAIM results in justifying the stability of the carbapenem-LdtMt2 complexes denoted by 
ONIOM Gibbs free binding interaction energies. 
  
43 
 
Table 3.  Second-order perturbation energies E (2) (kcal mol-1) corresponding to the most 
important charge transfer interaction (donor→ acceptor) in the carbapenem-LdtMt2 complexes 
at the B3LYP/6-31G level. 
Complex/ 
Interactions 
Donor NBO(i) n(O) Acceptor NBO(j) σ*(O─H) E (2) (kcalmol−1) 
(O)→σ*(O─H) 
Imi-LdtMt2     
HB1 BD (1) S36─H37 
LP (2) S36 
BD*(1) O56─H73 
BD*(1) O56─H73 
0.22 
15.80 
HB2 BD (1) C55─H60 
BD (1) C11─H12 
BD*(1) C11─H12 
BD*(1) C55─H60 
0.12 
0.28 
Tebi-LdtMt2     
HB1 BD (1) S36─H37  
LP (1) S36 
LP (2) S36 
BD*(1) O81─H82 
BD*(1) O81─H82 
BD*(1) O81─H82 
0.17 
1.64 
15.80 
HB2 BD (1) C11─H12 BD*(1) C80─H84 0.27 
Bia-LdtMt2     
HB1 BD (1) S70─H71 
LP (1) S70 
LP (2) S70 
BD*(1) O76─H79 
BD*(1) O76─H79 
BD*(1) O76─H79 
0.12 
2.77 
16.47 
HB2 BD (1) C75─H78 
BD (1) C45─H46 
BD*(1) C45─H46 
BD*(1) C75─H78 
0.22 
0.17 
Mero-LdtMt2     
HB1 BD (1) S81─H82 
LP (1) S81 
LP (2) S81 
BD*(1) O86─H87 
BD*(1) O86─H87 
BD*(1) O86─H87 
0.16 
1.42 
17.45 
HB2 BD (1) C85─H89 
BD (2) C56─N58 
BD (2) C56─N58 
BD*(1) C56─N58 
BD*(1) C85─H89 
BD*(1) C85─H89 
0.24 
0.73 
0.40 
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Figure 7.  Depiction of electron transfers for Imi-LdtMt2 complex derived by second-order 
perturbation theory of NBO analysis.  The curved arrows (a) depict the direction of charge 
transfer: (a) LP (S) → σ* (O─H) listed in Table 3. See other depictions in Figure 8S 
4.0 Conclusion 
In this study, a two-layered ONIOM (B3LYP/6-31+G(d): Amber) model was used to evaluate 
the efficacy of FDA approved carbapenems antibiotics towards LdtMt2 by calculating their 
binding interaction energies, hydrogen bond measurements, AIM and performing NBO 
analyses.  The four carbapenem-LdtMt2 complexes, namely Imi-LdtMt2, Tebi-LdtMt2, Bia-LdtMt2, 
and Mero-LdtMt2, were undertaken for this study.  The Gibb’s free energies (G) obtained in 
this study corresponded with the experimental trend.  As for enthalpies (H) and entropies 
(S), the favorable contributions of ligand–receptor electrostatic, hydrogen bond and van der 
Waals interactions to binding free energies for calculated complexes (carbapenems-LdtMt2) 
suggests a suitable theoretical model that can be useful in advancing the β-lactam antibiotics 
as potential anti-TB drug agents.  Moreover, the QTAIM topological indices provide an 
accurate indication of the critical hydrogen bond formation that contribute to the stability of 
the carbapenem-LdtMt2 complexes.  The AIM analysis agrees with the extent of charge transfer 
between carbapenems and LdtMt2 shown by the NBO second order perturbation theory.  NBO 
analysis was used to elucidate the data concerning charge transfer of electrons between 
carbapenems and LdtMt2.  Both analyses reveal that the prominent non-covalent interactions 
within the complexes correlates to the ONIOM calculated binding free energies. 
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The ONIOM method provides better relative binding free energies of these complexes than the 
previous molecular dynamics studies.  The outcome of this study highlights the nature of the 
non-covalent interactions of LdtMt2 with carbapenems which could be helpful for rational drug 
design of novel anti-TB drugs with relatively improved efficacies. 
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Abstract 
L, D transpeptidase plays a significant role in Mycobacterium tuberculosis (Mtb) during the 
biosynthesis of an impermeable cell wall structure.  LdtMt2 protein has attracted substantial 
attention of researchers as a known therapeutic target from Mtb.  β-lactam sub-class of 
antibiotics, carbapenems, have been deemed to have activity against this non-classical 
transpeptidases.  In this study, a hybrid two-layered ONIOM method was employed to examine 
molecular and electronic properties when a bridging water molecule is added to carbapenem—
LdtMt2 complex binding interface.  The active site residues (His187, Ser188, His203, Cys205 
and Asn207) together with carbapenems and water molecule were modelled at QM (B3LYP/6-
31+G(d)) level of theory and the remaining part of the enzyme was evaluated at MM level of 
theory (AMBER force field).  The obtained theoretical binding free energies (G) from 
ONIOM geometry optimization demonstrate that the presence of a water molecule in the 
carbapenem—LdtMt2 complexes has a substantial role during complexation process.  Both 
enthalpy (H) and entropy (S) had significant contributions in the binding free energies of 
carbapenem—LdtMt2 complexes.  Furthermore, AIM and NBO analysis corroborated the 
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significance of water in mediating hydrogen bond interactions which contributed to the stability 
and improved binding affinities of carbapenems.  Our results revealed the importance of a 
bridging water molecule in the carbapenem—LdtMt2 binding interfaces and this data could be 
useful in rational drug design. 
Keywords: Mycobacterium tuberculosis(Mtb), Carbapenems, LdtMt2, ONIOM, AIM, NBO 
1.0 Introduction 
In recent years, public health care has been confronted by the increase in cases of multi-drug 
resistant (MDR) and extensively drug-resistant (XDR) strains of M. tuberculosis1, 2.  Therefore, 
it is of great urgency to search for potent drug leads and explore new targets to counteract the 
burden of these increasingly dangerous species. 
A major contribution towards elusive elimination of Mtb is its complex peptidoglycan layer 
comprising of 4→3 and 3→3 cross-linkages generated by D, D- Transpeptidase and L, D-
Transpeptidase, respectively, during the last step of the biosynthesis process.  Inactivation of 
these enzymes is by means of disrupting the peptidoglycan cell wall biosynthesis, which will 
consequently destroy the bacteria.  A variety of bacterial species displays approximately 5–
10% of 3→3 cross linkages generated by L, D-Transpeptidase known to perform a significant 
role during the biosynthesis of peptidoglycan3.  Mtb is the only known mycobacterium to 
generate approximately 80% of 3→3 cross-linkages.  Therefore, L, D-Transpeptidase 2 has 
been seen as an attractive target towards eradication of Mtb as it is essential for virulence, 
growth and morphology4, 5. 
One of the most potent classes of antibacterial that have been studied is the β-lactam6 family 
of antibiotics.  This class of compounds are characterized by their efficacious inhibitory activity 
against D, D-transpeptidases6.  The inhibition of both enzymes, simultaneously, is essential for 
halting their significant cross-linking function.  The β-lactam class of antibiotics targets 
peptidoglycan biosynthesis and is broadly used as the treatment for bacterial infections but they 
have been deemed to be impotent as TB treatment7.  The inefficacious of β-lactams against M. 
tuberculosis has been impaired by the presence of the chromosomally encoded β-lactamases 
(BlaC), that hydrolyse the β-lactam ring thus resulting in drug deactivation.8  However, the 
inhibition of BlaC has been achieved with clavulanate thus making it possible to repurpose and 
optimize the use of carbapenems as potential therapeutic drug candidates for TB. 
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Several studies have reported carbapenems to have anti-TB activity9, 10.  In-vitro studies of 
biapenem, meropenem and tebipenem have indicated their potency/activity against Mtb even 
when administered alone or in combination11, 12.  The structural data for LdtMt2 bound to either 
peptidoglycan fragment or meropenem have been reported5.  Several theoretical studies 
exploring the inhibition mechanism using different molecular methods have evolved13-15.  The 
QM/MM molecular dynamic (MD) simulation and umbrella sampling approaches yielded 
insightful measures of the inactivation process rendered by meropenem and imipenem 
respectively.  However, the theoretical values found for the calculated inhibition mechanism 
correspond with the kinetic experimental energy values13.  Moreover, a 25 ns MD simulation 
study revealed the insightful binding free energy profiles of carbapenems against ex-LdtMt2 
using MM/GBSA and SIE methods14.  Recently our group reported an extensive 140 ns 
molecular dynamics simulation study with explicit water solvent exploring the role of the β-
hairpin flaps of LdtMt2 during the complexation process which were assumed to have 
considerable influence in accommodating the substrate and inhibitor in the active site15.  The 
results obtained in that study revealed that ertapenem and meropenem have lower binding free 
energies (-40.42 kcal mol-1, -37.91 kcal mol-1) than  imipenem (-34.47 kcal mol-1) and that was 
observed in a closed conformation of the β-hairpin flap15.  Also, the study conducted by 
Bianchet et al.16 conferred the crucial molecular interactions between carbapenems (biapenem 
and tebipenem) and the LdtMt2 with a possible S-conjugation mechanism of inactivation prior 
to binding.  According to their observations, biapenem and tebipenem bind to and inactivate 
the LdtMt2 from an outer cavity of the binding site
16.  The study conducted by Lu et al.17 
revealed the significance of bridging water molecules in the GSK3 β-inhibitors interfaces by 
facilitating the hydrogen bonding interactions so as to induce the affinity of inhibitors and also 
improve the stability in the GSK3 β-inhibitor complexes.  The role of water molecules in drug 
design is gaining attention and numerous studies have emphasized their influence in binding 
affinities of ligands18. 
The focus of this study was to exploit a two-layered ONIOM computational model to 
investigate the role played by the explicit water molecule to successfully bridge (hydrogen 
bonding) the carbapenems (biapenem, imipenem, meropenem and tebipenem) with LdtMt2 
during the complex formation.  Also, we opted to ascertain the nature of binding nature and 
determine the binding interactions energies for carbapenem-water-LdtMt2 upon complexation.  
Since water molecules are classified as a vital structural feature in protein-ligand complexes 
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that mediate intermolecular interactions (hydrogen bond formation), we believe that the 
stability of the carbapenem-LdtMt2 complexes will be improved.   
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Figure 1.  Structural representation of the studied carbapenems 
2.0 Material and methods 
2.1 System preparation  
The PBD complex structures of Mtb LdtMt2 were prepared by superimposing chain A of 3TUR
5 
complexed with the natural substrate and 3VYP19 meropenem-bound complex.  The covalently 
bound meropenem from 3VYP19 was restored by deletion of the covalent bond between the 
sulfur atom of cysteine residue and the carbonyl carbon of β-lactam ring.  The β-lactam ring 
was restored; the hydrogen atoms were added, and the inhibitor was moved about 3.5 Å away 
from the R-SH (cysteine) group.  A water molecule from the crystal structure (PDB ID: 3TUR5) 
was added between the inhibitor and the cysteine R-SH group.  The meropenem-bound 
complex was then optimized.  This optimized structure was then used as a reference to model 
other complexes by overlaying other inhibitors using PyMOL20. 
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A molecular dynamics (MD) calculation was performed on the starting complex to affix the 
missing protons using X-leap21 software.  The MD simulations were carried out using Amber 
14 with the ff99SB22 force field (for proteins) and GAFF23 for the inhibitors.  The complexes 
were solvated with TIP3P24 explicit water in a cubic box with 10 Å distance and counterions 
were added to neutralize the complexes.  Partial Mesh Ewald (PME)25 method was applied for 
long range electrostatic forces with cut-off of 12 Å. All bonds to hydrogen atoms was 
constrained using SHAKE algorithm26.  Two-stage geometric minimization was performed by 
2500 steps of steepest decent minimization followed by 2500 of conjugated gradient to remove 
clashes and bad contacts.  To accurately assign the protonation states of the residues in the 
enzyme at pH=7.8, the empirical PropKa web server27 was used.   
The prepared complexes were then evaluated with a two-layered ONIOM28-32 method.  The 
ONIOM input files together with the optimized output files of all carbapenem-LdtMt2 
complexes are provided in PDB format with the supplementary materials. 
2.2 ONIOM hybrid (QM:MM) method  
An efficient hybrid method used for investigating large biosystems was applied and all 
calculations were executed using the Gaussian09 program33.  The Becke3LYP51, 52 functional 
has been applied in several studies34-36 for it reliable accuracy of producing relatively good 
energies as to that of high-level ab initio methods.  The ONIOM input files were prepared and 
visualized using Gauss View 5 program33.  Using the DFT method, the best minimum energy 
conformations were achieved by full geometrical optimization of each conformer. 
In this study, a two-layered ONIOM28, 29, 37 hybrid approach (B3LYP/6-31G+(d): AMBER) as 
described by Morokuma et al.38 was used to evaluate the role of water contribution in the 
binding affinities of the selected carbapenems against LdtMt2.  The computational ONIOM
28-32 
model being investigated was evaluated with quantum mechanics (QM) and molecular 
mechanics (MM) methods in separate ONIOM layers.  The selected FDA-approved inhibitors 
together with an explicit water molecule and the catalytic active site residues of LdtMt2 enzyme 
(Cys205, His187, Ser188, His203, Asn207) were considered at QM level of theory and 
modeled using density functional theory (DFT)39, 40, B3LYP41, 42 functional and the 6-
31+G(d)43, 44 basis set.  The residual portion of the complex was considered at MM30, 45 and 
treated at low level of theory with the AMBER force field. 
To verify the local stable minimum point of the potential energy surface for carbapenem-LdtMt2 
complexes, frequency calculations were performed using the optimized ONIOM output 
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structures and consequently the vibrational frequencies for all carbapenem-LdtMt2 complexes 
were obtained with non-negative frequency. The total interaction energies are defined as:  
∆𝐸𝑂𝑁𝐼𝑂𝑀 = ∆𝐸𝑟𝑒𝑎𝑙,𝑙𝑜𝑤 +  ∆𝐸𝑚𝑜𝑑𝑒𝑙,ℎ𝑖𝑔ℎ −  ∆𝐸𝑚𝑜𝑑𝑒𝑙,𝑙𝑜𝑤                                           (𝟏) 
Where, ∆Emodel represent the energies of the model system defined at high and low level of 
theory and ∆Ereal represent the whole (real) system.  Thus, the equivalent binding interaction 
ONIOM energies of the complex systems are determined as follows: 
∆𝐺𝑂𝑁𝐼𝑂𝑀 ≈ ∆𝐺 = 𝐺𝑐𝑎𝑟𝑏𝑎𝑝𝑒𝑛𝑒𝑚―LdtMt2 – (𝐺LdtMt2 + 𝐺carbapenem )                                    (𝟐) 
The thermodynamic properties (enthalpies and entropies contributions) were also achieved 
from frequency calculations.  The different entropic contributions (rotation, translation, and 
vibration) for carbapenem―LdtMt2 complexes were calculated as follows:  
∆𝑆𝑡𝑜𝑡𝑎𝑙 = ∆𝑆𝑐𝑎𝑟𝑏𝑎𝑝𝑒𝑛𝑒𝑚−LdtMt2 − (∆𝑆𝑐𝑎𝑟𝑏𝑎𝑝𝑒𝑛𝑒𝑚𝑠 + ∆𝑆LdtMt2)                                     (𝟑) 
After the procurement of the thermodynamic properties, the natural bond orbital (NBO)46, 47 
and quantum theory of atoms in molecules (QTAIM)48 analysis were performed using the 
optimized structures to show the nature and stability of hydrogen bonds.  Moreover, the 
topological properties i.e. electron density (ρ(r)) and its Laplacian (∇2ρ(r)) at bond critical 
points (BCPs), were computed based on Bader’s QTAIM using the AIM2000 package49. 
3.0 Result and Discussion 
It may be noted that the computational model exploited in this study consist of water molecule 
confined in the protein-ligand interfaces (active site) evaluated using a two-layered ONIOM 
method.  To successfully understand the role of water during the binding process of FDA 
approved carbapenems, the binding free energy calculations of the carbapenem-water-LdtMt2 
complexes were executed using a two-layered ONIOM computational model (Figure 2).  The 
structural water involvement in this setting was aimed to enhance the energetics of protein-
ligand complexes by inducing carbapenems affinities towards LdtMt2.  The thermodynamic 
properties for the calculated theoretical results are reported in Table 1 and are comparable to 
the experimental data, except for two outliers.  As it was observed from the calculated 
theoretical binding free energies (G) (Table 1), Tebi-LdtMt2, Imi-LdtMt2 and Mero-LdtMt2 have 
approximately high theoretical values (-25.76 kcal mol-1, -19.35 kcal mol-1and -16.97 kcal mol-
1, respectively) compared to their experimental data, with Tebi-LdtMt2 being one of the outliers 
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that reversed the trend.  Also, Bia-LdtMt2 have demonstrated comparable binding free energies 
(theoretical and experimental) even though it is an outlier. 
Table 1.  The ONIOM binding interaction energies of carbapenem—water―LdtMt2 
complexes evaluated using (B3LYP/6-31+G (d): AMBER). 
Gibb’s free energy (G), Enthalpy change (H), Entropy change (S), S translational (Strans), S rotational 
(Srot), S vibrational (Svib). 
The computed binding free energies of the four complexes did not follow the experimental 
data, except for two complexes (outliers), the order was reversed in Tebi-LdtMt2 and Bia-LdtMt2.   
The ΔH value (-41.31 kcal mol-1) of Tebi-LdtMt2 complex (outlier) is the highest in all the 
investigated complexes.  For Imi-LdtMt2 and Mero-LdtMt2 complexes, their H values (-35.15 
kcal mol-1 and -33.69 kcal mol-1) implies that are reasonable binders too.  However, the Bia-
LdtMt2 complex shows the least enthalpy penalty than other complexes (Table 1). 
In the case of entropy contribution (S), the Tebi-LdtMt2 and Imi-LdtMt2 complexes have less 
entropy penalty (-52.18 cal mol-1 K-1 and cal mol-1 K-1) than other complexes.  However, the 
complexes (Bia-LdtMt2 and Mero-LdtMt2) that are weak binders in this study appear to have 
larger entropy penalty.  The translational and rotational entropy contributions are in close range 
for all complexes.  Interestingly, the major entropy contribution is from the vibrational 
component. 
  
Complexes Gbind(Exp) 
kcal mol-1
Gbind(Calc)  
kcal mol-1 
H 
kcal mol-1 
STotal 
cal mol-1 K-1 
Strans 
cal mol-1 K-1 
Srot 
cal mol-1 K-1 
Svib 
cal mol-1 K-1 
Tebi—LdtMt2 -9.35 -25.76 -41.31 -52.18 -43.68 -36.27 27.77 
Imi—LdtMt2 -9.82 -19.35 -35.15 -53.07 -42.95 -34.79 24.67 
Mero—LdtMt2 -8.16 -16.97 -33.69 -56.07 -43.68 -35.98 23.59 
Bia—LdtMt2 -8.96 -7.94 -25.66 -59.44 -43.43 -35.48 19.48 
57 
 
Distance analysis of the carbapenem—LdtMt2 complexes  
Distance is one of the significant measure in non-covalent interacting molecules.  As a result, 
to understand and justify the obtained Gibb’s binding free energies, the selected distances of 
each complex were measured before and after optimization to show the significant discrepancy 
between the carbonyl carbon of β-lactam ring (C), water (O) and sulfur atom of cysteine residue 
(S).  The distances are reported in Table 2.  It was observed that in all carbapenem-LdtMt2-
water calculations, the distances increased significantly after optimisation.  When the C-O 
distances are compared, the figure for Tebi-LdtMt2 (4.45 A) deviates considerably, from the 
values of the other complexes.  For this complex, the C-S distance is the shortest of all 
complexes.  It is possible these complexes are trapped in different local minima, leading to 
binding energies that differ from the experimental binding energies.  Alternatively, it is possible 
that the subsequent activation energies are rate determining and that the energies of the 
precomplexes are not so crucial.  This would mean that this model is not suitable for observing 
a correlation between the binding energies of the precomplexes, and the experimental binding 
energies. 
Table 2.  Distance analysis in angstroms (Å) between carbonyl carbon of β-lactam ring (C)-
water(O)-sulfur(S) 
Complexes Interactions  Before 
optimization 
After 
optimization 
Bia—LdtMt2—water C—O 3.19 3.32 
 O—S 2.35 3.31 
 C—S 3.51 3.91 
Imi—LdtMt2—water C—O 3.12 3.44 
 O—S 2.35 3.42 
 C—S 3.51 3.88 
Mero—LdtMt2—water C—O 3.25 3.31 
 O—S 2.35 3.30 
 C—S 3.51 3.81 
Tebi—LdtMt2—water C—O 3.24 4.45 
 O—S 2.35 3.30 
 C—S 3.51 3.76 
The hydrogen bond interactions of carbapenem—LdtMt2—water complexes 
Bridging water molecules are of great significance in protein active site and they can also 
regulate the number of hydrogen bond interactions between the protein and ligands18.  It is 
evident that water molecule interacted with both the carbapenems and LdtMt2 by forming crucial 
58 
 
H-bond links that significantly stabilized the complex and improved the correlation between 
theoretical and the experimental binding free energy results (Table 1).  The water molecule 
interacts (H-bond) with the hydroxyethyl group of the carbapenems while the oxygen of water 
also forms a H-bond with the carbonyl oxygen of carbapenems.  The Ser192 and Asn207 serve 
as hydrogen donors to the carbapenem while Thr171 forms hydrophobic interaction with the 
carboxyl group of carbapenem and Cys205 serve as a H-bond acceptor (Figure 2).  Also see 
other data in Figure 1S.  In Figure 2, the hydrogen bond interactions of carbapenem-LdtMt2 
complexes obtained after geometry optimization (frequency calculations).  The water molecule 
served as H-bond donor-acceptor in this scenario.  To further examine the nature of binding 
interactions, the LigPlot50 program was used to plot the electrostatic and hydrogen bond 
interactions for LdtMt2 complexed with carbapenems.  The plots are depicted in Figure 3 and 
in the supplementary material (Figure 2S).  
Figure 2. 3-D structural features of the hydrogen bond and hydrophobic interactions of 
carbapenems, LdtMt2 and the water molecule (W01). 
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Figure 3. 2-D schematic representation of hydrogen bond and hydrophobic interactions 
between catalytic amino acid residues and the carbapenems (A. Biapenem and B. Meropenem).  
Red dotted lines represent hydrogen bond interactions. 
QTAIM analysis  
The quantum theory of atoms in molecules (QTAIM) have been applied to describe and 
calculate the H-bond interactions for carbapenem-LdtMt2 complexes
51, 52.  From the last 
optimized geometry of the carbapenem-LdtMt2 complexes, the QM region comprising of the 
active site residues (His187, Ser188, His203, Cys205 and Asn207) and the selected 
carbapenems, were used to calculate the wave function using B3LYP/6-31G+(d).  The resulting 
wave function output files were then employed to perform ab initio calculations to generate the 
electron topography of carbapenem-LdtMt2 complexes using AIM2000 software package
53.  
The topological parameters of these complexes were collected and analysed at each bond 
critical point (BCP) as shown by HB in Figure 3 (a. Imi-LdtMt2 and b. Bia-LdtMt2 complexes).  
The topological parameters for the carbapenem-LdtMt2 complexes are tabulated in Table 2.  In 
general,  the existence of hydrogen bonds are assumed by electron density ρ(r) and Laplacian 
of electron density ∇2 ρ(r) values that range between 0.002-0.035 a.u and 0.024-0.139 a.u., 
respectively54. 
The reported data for the ρ(r) and ∇2 ρ(r) in Table 2 differs according to each bond critical 
point it was collected from as denoted by HB’s.  However, the standard measure for both the 
ρ(r) and ∇2 ρ(r) in the carbapenem-LdtMt2 complexes range from 0.0001-0.0434 and 0.0003-
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0.1194 a.u, respectively.  The ρ(r) and ∇2 ρ(r) shows the strength of the hydrogen bond 
interactions and validate the presence of hydrogen bonds at each BCP as shown in Figure 4. 
It was observed in all complexes that both strong and weaker binders, the hydrogen bonds in 
the QM region, have more strength as measured by ρ(r) and ∇2 ρ(r) values in Table 2.  It is 
worth noting that the sign of ∇2 ρ(r) determines the charge density whether it is locally depleted 
∇2 ρ(r)>0, or locally concentrated ∇2 ρ(r)<0.  Furthermore, the strength of the hydrogen bonds 
is also determined by the H(r)<0 and ∇2 ρ(r)<0 for strong hydrogen bonds, while H(r)<0 and 
∇2 ρ(r)>0, determine medium hydrogen bonds and H(r)>0, and ∇2 ρ(r)>0 denotes weak 
hydrogen bond interactions48.  The sign of the ∇2 ρ(r) and H(r) values (Table 2) indicate the 
nature of the bonds i.e. positive value of ∇2 ρ(r) and the negative value of H(r) indicates that 
the bond type is partially covalent-partially electrostatic (Pc-Pe)55.  See details for other 
complexes in Table 1S. 
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Table 3. AIM topological parameters of carbapenem―LdtMt2 complexes calculated at the 
B3LYP/6-31+G(d). Electron density (ρ) and their Laplacian of electron density (▽2ρ) in a.u. 
and energetic parameters G(r), H(r), and V(r) in (kcal/mol) 
KEG, Lagrangian kinetic energy density G(r), KEK, Hamiltonian kinetic energy density H(r), VIR, Virial filed 
function V(r). 
NBO analysis 
The last optimized ground state geometries of the QM region of the carbapenem-LdtMt2 
complexes were used to calculate the distribution of electron density in atoms using the 
B3LYP/6-311+G(d).  In the NBO analysis46, occupied Lewis and a set of unoccupied non-
Lewis localized orbitals are explained based on the electronic wave function.  The NBO donor-
acceptor (bond-antibonding) interactions were assessed.  The strengths of the delocalization 
interactions E(2) are approximated by second order perturbation theory46.  The stabilization 
energies associated with delocalization of electrons in the strongest in HB’s with S···· H─O 
Hydrogen bonds Complexes 
interactions 
ρ (r) ▽2ρ (r) G(r) H(r) V(r) Ellipticity (ε) 
 Imi—LdtMt2       
HB1 C80H···C39 0.0001 0.0003 0.00005 -0.00003 0.00002 2.7859 
HB2 O71···H34C 0.0169 0.0559 0.0137 -0.0003 0.0134 0.0430 
HB3 O90···H72O 0.0217 0.0723 0.0184 0.0003 0.0187 0.0270 
HB4 O82···H73O 0.0329 0.1064 0.0274 0.0008 0.0282 0.1092 
HB5 O71···H30N 0.0143 0.0526 0.0124 -0.0007 0.0117 0.0865 
HB6 O90H···S53 0.0198 0.0495 0.0127 0.0004 0.0131 0.0271 
HB7 O108···H67N 0.0163 0.0644 0.0149 -0.0012 0.0137 0.0370 
HB8 C89H···C11 0.0050 0.0162 0.0030 -0.0010 0.0020 0.2725 
 Bia—LdtMt2       
HB1 C83H···C39 0.0027 0.0095 0.0018 -0.0006 0.0012 1.0611 
HB2 S71···H40C 0.0009 0.0026 0.0005 -0.0002 0.0003 1.4043 
HB3 C77H···O115 0.0060 0.0213 0.0043 -0.0010 0.0033 0.4363 
HB4 O107···H115O 0.0247 0.0794 0.0206 0.0007 0.0213 0.0875 
HB5 O115···H34C 0.0192 0.0630 0.0157 -0.00004 0.0157 0.0739 
HB6 O72···H117O 0.0233 0.0760 0.0194 0.0004 0.0199 0.0422 
HB7 O115H···S53 0.0093 0.0368 0.0075 -0.0016 0.0059 0.5410 
HB8 O72···H30N 0.0086 0.0333 0.0074 -0.0010 0.0064 0.0579 
HB9 O107H···S53 0.0205 0.0516 0.0134 0.0005 0.0138 0.0484 
HB10 C105H···C11 0.0065 0.0218 0.0042 -0.0013 0.0029 0.0332 
HB11 C84O···H67N 0.0136 0.0549 0.0124 -0.0013 0.0111 0.0962 
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and O····H—O type of interactions being mediated by water across all the carbapenem-LdtMt2 
complexes.  In the Imi-LdtMt2 complex, the dominant interatomic interactions are observed in 
HB2, HB3, HB6 and HB7.  For Tebi-LdtMt2, it was demonstrated that HB4, HB5 and HB9 
have the strongest stabilization energy as shown in Table 3. 
Figure 4.  Molecular graph of A. Imi―LdtMt2 and B. Bia―LdtMt2 complexes generated using 
AIM2000 software. Small red spheres and lines correspond to the bond critical points (BCP) 
and the bond paths, respectively.  See details of the molecular graph for other complexes in 
Figure 3S 
It is worth pointing out that other HB’s from carbapenem-LdtMt2 complexes contributed 
significantly in electron charge transfer.  This observation reveals that there was a great deal of 
electron charge transfer from donor to acceptor units in the presence of water molecule (Table 
3).  The charge transfer between the lone pair (LP) and the anti-bonding (BD*) orbitals are 
shown in Figure 5 and Figure 4S.  The hydrogen bonds between interacting atoms provide 
satisfactory evidence for significant electron charge transfer from the lone pair orbital to anti-
bonding orbital.  Therefore, the NBO analysis corresponds with the QTAIM results in 
qualifying the stability of the carbapenem-LdtMt2 complexes as represented by the ONIOM 
Gibbs binding free energies. 
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Table 4.  Second-order perturbation energies E (2) (kcal mol-1) corresponding to the most 
important charge transfer interaction (donor→ acceptor) in the carbapenem-LdtMt2 complexes 
at the B3LYP/6-31+G (d) level.  Table 1S 
  
Complex/ Interactions Donor NBO(i) n(O) Acceptor NBO(j) σ*(O─H) E (2) (kcalmol−1) 
(O)→σ*(O─H) 
Imi—LdtMt2    
HB1 BD (1) C80─H88 BD*(1) C39─H40 - 
HB2 BD (1) O71 
LP (1) O71 
BD*(1) C33─H34 
BD*(1) C33─H34 
0.13 
5.06 
HB3 BD (1) O90─H107  
LP (1) O90 
LP (2) O90 
BD*(1) O71─H72 
BD*(1) O71─H72 
BD*(1) O71─H72 
0.20 
2.06 
4.35 
HB4 BD (1) C76─O82 BD*(1) O71─H73 0.22 
HB5 BD (1) N29─H30 
BD (1) O71─H72 
LP (1) O71 
LP (2) O71 
BD*(1) O71─H72 
BD*(1) N29─H30 
BD*(1) N29─H30 
BD*(1) N29─H30 
0.27 
0.23 
1.67 
0.77 
HB6 BD (1) S53─H54 
LP (1) S53 
LP (1) S53 
BD*(1) O90─H107 
BD*(1) O90─H107 
BD*(1) O90─H107 
0.20 
1.10 
12.11 
HB7 BD (1) C81─H108 
LP (1) O108 
LP (2) O108 
BD*(1) N66─H67 
BD*(1) N66─H67 
BD*(1) N66─H67 
0.12 
6.34 
0.10 
HB8 BD (1) C11─N13 
BD (2) C11─N13 
BD (2) C11─N13 
BD*(1) C89─H94 
BD*(1) C89─H94 
BD*(1) C89─H94 
0.20 
0.26 
0.27 
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Figure 5.  Depiction of electron transfers for Imi—LdtMt2 complex derived by second-order 
perturbation theory of NBO analysis.  The curved arrows (a, b, c, d and e) depict the direction 
of charge transfer: (a) LP (O) → σ* (C─H) (b) LP (O) → σ* (O─H) (c) LP (O) → σ* (N─H) 
(d) LP (S) → σ* (O─H) and (e) LP (O) → σ* (N─H) listed in Table 3. See other depictions in 
Figure 4S. 
4.0 Conclusion  
In this study, the role of the catalytic water molecule at the protein active site of LdtMt2 
complexed with four FDA approved carbapenems.  A two-layered ONIOM method was 
applied to evaluate the effect of bridging water molecule in the protein-inhibitor interface.  In 
the context of the binding event, the solvent plays a significant role in the interactions.  The 
results for Tebi-LdtMt2, Imi-LdtMt2, Mero-LdtMt2 and Bia-LdtMt2 complexes reflect reasonable 
Gibb’s binding free energies which corresponded with the experimental data with exceptions 
of two outliers.  The Gibb’s order for the binding free energies of Tebi-LdtMt2 and Bia-LdtMt2 
complexes was reversed.  The contribution of the water molecule in mediating hydrogen bond 
formation/breaking varied significantly in each carbapenem-LdtMt2 complex as seen in the 
binding free energy results.  It is worth mentioning that the distance between carbapenem; 
water and the protein have a significant impact in binding free energy.  The QTAIM and NBO 
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analysis were carried out to assess the hydrogen bond interactions and delocalization of 
electron charge, respectively, to ascertain the nature and stability of hydrogen bond interactions 
and electron charge transfer in the protein-ligand-water interfaces.   
The precision of the water modelling is vital for accurate prediction of binding free energy and 
insightful binding kinetics of ligands.  The data provided in this study can be used to improve 
the reliability of the computational model by using suitable methods for calculating the energy 
contribution of water molecules in the protein-ligand complexes.  Future studies should 
determine whether any of these precomplexes are trapped in a local minimum and if that can 
be overcome by optimising all complexes with the same constrained interatomic distances (see 
Table 2).  Alternatively, the activation energies of the bond formation step should be 
calculated. 
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CHAPTER FOUR 
CONCLUSION 
Understanding the inactivation mechanisms of carbapenems against L, D transpeptidase 2 
(LdtMt2) is of great importance.  In this regard, carbapenems have been shown to have a 
remarkable activity against L, D-transpeptidases, particularly LdtMt2.  In this thesis, a highly 
efficient hybrid ONIOM approach was applied to investigate the no-covalent interactions in 
carbapenems— LdtMt2 complexes which regulates the efficiency of carbapenems against 
LdtMt2. 
A comprehensive study established in chapter two of this thesis examined the binding free 
energies of the carbapenems against the significant non-classical L, D-Transpeptidase 2 from 
Mycobacterium tuberculosis using a hybrid two-layered ONIOM approach. The QM/MM 
geometry optimization of the four FDA approved carbapenems complexed with LdtMt2 were 
performed using hybrid two-layered ONIOM (B3LYP/6-31G+(d):AMBER) model, where the 
density functional theory [B3LYP/6-31G(d)] was used for QM region and MM region 
evaluated with Amber force field.  It was observed that the theoretically calculated relative 
binding free energies (G) for FDA approved carbapenems complexed with LdtMt2 correspond 
with the experimentally observed data.   
In addition, the important amino acid residues which were in proximity with the ligand were 
involved in hydrogen bond formation which thus had a significant contribution in the Gibbs 
binding free energies and stability of the complexes.  The quantum theory of atoms in 
molecules (QTAIM) authenticated the existence of hydrogen bond interactions. Furthermore, 
the stabilization energy, E(2), obtained by NBO second-perturbation energy analysis revealed 
the electron charge transfer between carbapenems and active residues of LdtMt2.  These 
analyses agreed in principle with the calculated Gibb’s binding free energies.  For further model 
refinement to justify our observation, we investigated the water involvement in the binding site 
by adding explicit water molecule in the active site to ascertain more insight in the binding 
process. 
The role of water molecules in drug design is increasingly being considered to strengthen the 
binding kinetics of the ligands.  Previously, our group explored the six-membered ring 
mechanistic study involving catalytic water and the observed thermochemical outcomes 
revealed the significance of water which motivated us to consider water molecule in this study.  
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A study established in chapter three of this thesis demonstrated the effect of water confined in 
the active site of LdtMt2 complexed with carbapenems.  The water molecule, active site residues 
and carbapenem were considered at the QM [B3LYP/6-31G(d)] level of theory.  It was revealed 
that the calculated relative binding free energies for the carbapenem—LdtMt2—water 
complexes followed the experimental trend, exceptions for two outliers.  The trend in Bia—
LdtMt2 and Tebi—LdtMt2 was reversed.  Also, the distance discrepancies between the carbonyl 
carbon of β-lactam ring (C), water (O) and sulfur atom of cysteine residue (S) demonstrated a 
significant contribution to the binding free energies (G). In addition, the QTAIM and NBO 
analysis revealed the great deal of hydrogen bond interactions and electron charge 
delocalization in the interface that contributed to the binding free energies (G).  This analysis 
corroborated with the reported theoretical and experimental results. 
In conclusion, the overall calculated binding free energies reported in this study for 
carbapenem─LdtMt2 complexes correlated with the experimental data except for two outliers 
evaluated and discussed in chapter three of this thesis. Also, this could infer from our study 
that ONIOM approach can be used as a reliable molecular orbital technique to compute the 
binding free energies for carbapenem─LdtMt2 complexes.  The data obtained in this study can 
be tailored for rational drug design of potent therapeutic drugs for TB.  
Recommendation  
Future studies should involve the optimization of inhibitor plus one water molecule 
precomplexes with the same constrained interatomic distances since it seems that some of them 
are trapped in a local minimum.  Afterwards, the optimization of these complexes without any 
constraints must be performed to observe if the energies then follow experiment.  Alternative, 
the activation energies of the bond formation in the acylation step should be calculated.  Also, 
to validate the potential role of water in the reaction mechanism, the activation energies for 
these inhibitors can be calculated the using a 6-membered ring TS model with water and the 
enzyme residues. 
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APPENDIX A 
Supplementary Material for Chapter Two 
ONIOM study of the binding interaction energies for the carbapenems 
complexed with L, D-Transpeptidase 2 from Mycobacterium tuberculosis  
Thandokuhle Ntombela, a Zeynab Fakhar, b Collins U. Ibeji, a Thavendran Govender, a 
Glenn E. M. Maguire, a, c Gyanu Lamichhane, d Hendrik G. Krugera* and Bahareh 
Honarparvara*  
 
The supplementary material for the investigated carbapenem—LdtMt2 complexes. 
 
Figure 1S.  The superimposed 3D structures of 3TUR (LdtMt2 in complex with peptidoglycan 
fragment as natural substrate) in purple and 3VYP (meropenem―LdtMt2 adduct) in green for 
the selected carbapenem―LdtMt2 complexes. 
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Figure 2S.  The 3D structures of 3TUR superimposed with carbapenem―LdtMt2 complexes. 
(a) Biapenem―LdtMt2  (b) Imipenem―LdtMt2  (c) Meropenem―LdtMt2  (d) Tebipenem―LdtMt2   
Figure 3S.  3D-structures of carbapenem―LdtMt2 complexes showing poses obtained after 
frequency calculations. (A)  Biapenem―LdtMt2 (B)  Tebipenem―LdtMt2  
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Table 1S: The ONIOM binding interaction energies of carbapenem―LdtMt2 complexes 
evaluated using (B3LYP/6-31+G (d): AMBER).  
Gibb’s free energy (G), Enthalpy change (H), Entropy change (S), S translational (Strans), S rotational 
(Srot), S vibrational (Svib). 
 
Figure 4S A two-layered QM:MM ONIOM (B3LYP/6-31G+(d): AMBER) model of (A)Imi—
LdtMt2, (B) Mero—LdtMt2 and (C)Tebi—LdtMt2 complexes.  Active site residues His187, Ser188 
and Cys205 were also treated at the same QM level. 
 
Complexes G 
kcal mol-1 
H 
kcal mol-1 
S 
cal mol-1 K-1 
Strans 
cal mol-1 K-1 
Srot 
cal mol-1 K-1 
Svib 
cal mol-1 K-1 
Tebi-LdtMt2 -35.92 -52.74 -56.42 -43.68 -36.26 23.52 
Imi-LdtMt2 -30.38 -46.49 -54.05 -42.95 -34.80 23.70 
Bia-LdtMt2 -25.03 -42.84 -59.75 -43.43 -35.49 19.17 
Mero-LdtMt2 -24.27 -48.73 -54.42 -43.68 -36.00 25.26 
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Figure 5S: Schematic representation of hydrogen bond and intermolecular interactions and 
their respective distances before and after optimization. A. Bia―LdtMt2 B. Imi―LdtMt2 and C. 
Tebi―LdtMt2  
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Figure 6S.  A 2-D schematic representation of hydrogen bond and hydrophobic interactions 
between catalytic amino acid residues and the carbapenems A. Bia—LdtMt2 and B. Tebi—
LdtMt2.  Hydrogen bonds are denoted with dashed line and hydrophobic interactions are shown 
as arcs. Both the figures were made using LigPLOT program. 
  
76 
 
Figure 7S.  Molecular graph of A. Bia―LdtMt2 and B. Tebi―LdtMt2 complexes generated 
using AIM2000 software.  Small red spheres and lines correspond to the bond critical points 
(BCP) and the bond paths, respectively. 
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Figure 8S.  Depiction of electrons transfer for carbapenem―LdtMt2 complexes derived by 
second-order perturbation theory of NBO analysis.  The curved arrow (a) depict the direction 
of charge transfer from lone pair to antibonding (LP→ σ*): (A) Bia―LdtMt2 (B) Mero―LdtMt2 
and (C) Tebi―LdtMt2 as listed in Table 3. 
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APPENDIX B 
Supplementary Material for Chapter Three 
ONIOM study of carbapenems binding interaction energies against L, D 
transpeptidase2 from Mycobacterium tuberculosis with explicit water 
molecule confined in the active site 
Thandokuhle Ntombela, a Zeynab Fakhar, a Gideon F. Tolufashe, a Thavendran 
Govender, a Glenn E. M. Maguire, a, b Gyanu Lamichhane, c. Bahareh Honarparvar, a* 
and Hendrik G. Krugera* 
 
Figure 1S.  3-D structural features (hydrogen bond and hydrophobic interactions) of 
carbapenems— LdtMt2—water complexes. Water molecule is denoted as W01 
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Figure 2S. 2-D schematic representation of hydrogen bond and hydrophobic interactions 
between catalytic amino acid residues and the carbapenems (A. Biapenem and B. Meropenem).  
Red dotted lines represent hydrogen bond interactions 
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Table 1S. AIM topological parameters including electron density (ρ) and their Laplacian of 
electron density (▽2ρ) in a.u. and energetic parameters G(r), H(r), and V(r) in (kcal/mol) in 
carbapenem―LdtMt2 complexes calculated at the B3LYP/6-31+G(d).  
Hydrogen 
bonds 
Complexes 
interactions 
ρ (r) ▽2ρ (r) G(r) H(r) V(r) Ellipticity 
(ε) 
 Mero—LdtMt2       
HB1 C89H···N37 0.0033 0.0109 0.0021 -0.0006 0.0016 0.8872 
HB2 O71···H34C 0.0201 0.0671 0.0167 -0.00009 0.017 0.0852 
HB3 C83H···O71 0.0096 0.0336 0.0073 -0.0011 0.0062 0.2154 
HB4 O120···H72O 0.0242 0.0761 0.0198 0.0008 0.0201 0.0857 
HB5 O75···H73O 0.0176 0.0578 0.0145 0.00009 0.0146 0.0562 
HB6 O71H···S53 0.0103 0.0406 0.0084 -0.0017 0.0068 0.3375 
HB7 O120H···S53 0.0188 0.0495 0.0124 0.00007 0.0125 0.0601 
HB8 O75···H67N 0.0101 0.0374 0.0085 -0.0008 0.0077 0.0627 
HB9 C119H···C11 0.0049 0.0164 0.0031 -0.0010 0.0021 0.1342 
HB10 O76H···O65C 0.0426 0.1401 0.0356 0.0005 0.0361 0.0305 
HB11 C94O···H12C 0.0061 0.0238 0.0050 -0.0010 0.0040 0.0427 
 Tebi—LdtMt2       
HB1 C86H···N37 0.0040 0.0127 0.0026 -0.0006 0.0019 1.4200 
HB2 O71···H34C 0.0170 0.0520 0.0131 0.00009 0.0132 0.0524 
HB3 O71···H30N 0.0072 0.0267 0.0058 -0.0009 0.0049 0.1881 
HB4 O115···H73O 0.0370 0.1194 0.0310 0.0012 0.0322 0.0334 
HB5 O115H···S53 0.0260 0.0593 0.0166 0.0018 0.0184 0.0446 
HB6 O75···H67N 0.0097 0.0634 0.0083 -0.0008 0.0074 0.04616 
HB7 O75···H12C 0.0014 0.0058 0.0010 -0.0004 0.0006 0.4056 
HB8 C114H···C11 0.0048 0.0154 0.0029 -0.0010 0.0019 0.0991 
HB9 O77H···O65 0.0434 0.1380 0.0357 0.0012 0.0369 0.0126 
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Figure 3S.  Molecular graph of A. Mero―LdtMt2 and B. Tebi―LdtMt2 complexes generated 
using AIM2000 software. Small red spheres and lines correspond to the bond critical points 
(BCP) and the bond paths, respectively.  See details of the molecular graph for other complexes 
in  
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Table 2S. Second-order perturbation energies E (2) (kcal mol-1) corresponding to the most 
important charge transfer interaction (donor→ acceptor) in the carbapenem-LdtMt2 complexes 
at the B3LYP/6-31+G(d) level. 
Complex/ 
Interactions 
Donor NBO(i) n(O) Acceptor NBO(j) σ*(O─H) E (2) (kcalmol−1) 
(O)→σ*(O─H) 
Tebi—LdtMt2    
HB1 LP (1) N37 BD*(1) C86─H92 0.17 
HB2 BD (1) C33—H34 
BD*(1) O71─H73 
LP (1) O71 
BD*(1) O71─H73 
BD*(1) C33─H34 
BD*(1) C33—34 
0.12 
0.54 
5.28 
HB3 LP (1) O71  
LP (2) O71 
BD*(1) N29─H30 
BD*(1) N29─H30 
0.44 
0.60 
HB4 BD (1) O115─H116 
LP (1) O115 
LP (2) O115 
BD*(1) O71─H73 
BD*(1) O71─H73 
BD*(1) O71─H73 
0.95 
2.04 
15.50 
HB5 BD (1) S53─H54 
LP (1) S53 
LP (2) S53 
BD*(1) O115─H116 
BD*(1) O115─H116 
BD*(1) O115─H116 
0.48 
1.49 
17.75 
HB6 LP (1) O75 
LP (2) O75 
BD*(1) N66─H67 
BD*(1) N66─H67 
1.42 
1.59 
HB7 — — — 
HB8 BD (1) C11─H12 
BD (2) C11─N13 
BD*(1) C114─H118 
BD*(1) C114─H118 
0.14 
0.39 
HB9 BD (1) C64—O65 
BD (2) C64—O65  
LP (1) O65 
LP (2) O65 
BD*(1) O77—H113 
BD*(1) O77—H113 
BD*(1) O77—H113 
BD*(1) O77—H113 
0.79 
0.49 
7.84 
19.04 
Mero—LdtMt2    
HB1 LP (1) N37  BD*(1) C89—H103  
HB2 BD (1) C33—H34 
LP (1) O71 
LP (2) O71 
BD*(1) O71—H72 
BD (1) C33—H34 
BD (1) C33—H34 
0.27 
0.47 
7.74 
HB3 — — — 
HB4 BD (1) O120—H121 BD*(1) O71—H72 0.30 
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LP (1) O120 
LP (2) O120 
BD*(1) O71—H72 
BD*(1) O71—H72 
1.59 
6.42 
HB5 BD (1) O75—C85 
LP (1) O75 
LP (2) O75 
BD*(1) O71—H72 
BD*(1) O71—H72 
BD*(1) O71—H72 
0.21 
1.04 
3.29 
HB6 LP (1) S53 
LP (2) S53 
BD*(1) O71—H73 
BD*(1) O71—H73 
1.34 
0.14 
HB7 LP (1) S53 
LP (2) S53 
BD*(1) O120—H121 
BD*(1) O120—H121 
1.12 
10.89 
HB8 LP (1) O75 
LP (2) O75 
BD*(1) N66—H67 
BD*(1) N66—H67 
1.29 
1.59 
HB9 BD (2) C11—N13 BD*(1) C119—H123 0.54 
HB10 BD (1) C64—O65 
BD (2) C64—O65 
LP (1) O65 
LP (2) O65 
BD*(1) O76—H112 
BD*(1) O76—H112  
BD*(1) O76—H112  
BD*(1) O76—H112  
0.93 
2.36 
11.58 
13.35 
HB11 BD (1) O77—C34 
LP (1) O77 
LP (1) O77 
BD*(1) C11—H12 
BD*(1) C11—H12 
BD*(1) C11—H12 
0.15 
1.15 
0.51 
Bia—LdtMt2    
HB1 BD (1) C39—N41 BD*(1) C83—H90 0.10 
HB2 - - - 
HB3 LP (1) O115 
LP (1) O115 
BD*(1) C77—H86 
BD*(1) C77—H86 
0.13 
0.15 
HB4 BD (1) O107—H110 
LP (1) O107  
LP (2) O107 
BD*(1) O115—H116 
BD*(1) O115—H116 
BD*(1) O115—H116 
0.32 
1.85 
6.14 
HB5 BD (1) C33—H34 
BD (1) O115—H116 
LP (1) O115 
LP (2) O115 
BD*(1) O115—H116 
BD*(1) C33—H34 
BD (1) C33—H34 
BD (1) C33—H34 
0.31 
0.46 
0.76 
7.06 
HB6 BD (2) O72—C79 BD*(1) O115—H117 0.25 
HB7 LP (1) S53 BD*(1) O115—H117 1.00 
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LP (2) S53 BD*(1) O115—H117 0.16 
HB8 BD (1) O72—C79 
LP (1) O72 
BD*(1) N29—H30 
BD*(1) N29—H30 
0.46 
1.24 
HB9 BD (1) S53—H54 
LP (1) S53 
LP (2) S53 
BD*(1) O107—H110 
BD*(1) O107—H110 
BD*(1) O107—H110 
0.20 
1.30 
12.94 
HB10 - - - 
HB11 LP (1) O74 
LP (2) O74 
BD*(1) N66—H67 
BD*(1) N66—H67 
3.40 
0.72 
 
Figure 4S.  Depiction of electron transfers for Imi—LdtMt2 complex derived by second-order 
perturbation theory of NBO analysis.  The curved arrows (a, b, c, d, e, f, g, h and i) depict the 
direction of charge transfer: Table 2S 
